"soc","term","subjid","serious","related","fatal","group"
"Blood and lymphatic system disorders",2019-09-04,9,0,0,0,"Group A"
"Blood and lymphatic system disorders",2019-09-05,19,0,0,0,"Group A"
"Blood and lymphatic system disorders",2019-09-06,18,0,0,0,"Group A"
"Blood and lymphatic system disorders",2019-09-07,9,0,0,0,"Group A"
"Blood and lymphatic system disorders",2019-09-08,19,0,0,0,"Group A"
"Blood and lymphatic system disorders",2019-09-09,19,0,0,0,"Group A"
"Blood and lymphatic system disorders",2019-09-10,18,0,0,0,"Group A"
"Blood and lymphatic system disorders",2019-09-11,18,0,0,0,"Group A"
"Blood and lymphatic system disorders",2019-09-12,18,0,0,0,"Group A"
"Blood and lymphatic system disorders",2019-09-13,18,0,0,0,"Group A"
"Cardiac disorders",2019-09-14,11,0,0,0,"Group A"
"Cardiac disorders",2019-09-15,2,0,0,0,"Group A"
"Cardiac disorders",2019-09-16,16,0,0,0,"Group A"
"Cardiac disorders",2019-09-17,14,0,0,0,"Group A"
"Cardiac disorders",2019-09-18,11,0,0,0,"Group A"
"Cardiac disorders",2019-09-19,14,0,0,0,"Group A"
"Cardiac disorders",2019-09-20,11,0,0,0,"Group A"
"Cardiac disorders",2019-09-21,11,0,0,0,"Group A"
"Cardiac disorders",2019-09-22,2,0,0,0,"Group A"
"Cardiac disorders",2019-09-23,16,0,0,0,"Group A"
"Cardiac disorders",2019-09-24,11,0,0,0,"Group A"
"Cardiac disorders",2019-09-25,16,0,0,0,"Group A"
"Congenital, familial and genetic disorders",2019-09-26,15,0,0,0,"Group A"
"Congenital, familial and genetic disorders",2019-09-27,17,0,0,0,"Group A"
"Congenital, familial and genetic disorders",2019-09-28,15,0,0,0,"Group A"
"Congenital, familial and genetic disorders",2019-09-29,15,0,0,0,"Group A"
"Ear and labyrinth disorders",2019-09-30,4,0,0,0,"Group A"
"Ear and labyrinth disorders",2019-10-01,9,0,0,0,"Group A"
"Ear and labyrinth disorders",2019-10-02,19,0,0,0,"Group A"
"Ear and labyrinth disorders",2019-10-03,18,0,0,0,"Group A"
"Ear and labyrinth disorders",2019-10-04,11,0,0,0,"Group A"
"Ear and labyrinth disorders",2019-10-05,2,0,0,0,"Group A"
"Ear and labyrinth disorders",2019-10-06,16,0,0,0,"Group A"
"Ear and labyrinth disorders",2019-10-07,14,0,0,0,"Group A"
"Ear and labyrinth disorders",2019-10-08,11,0,0,0,"Group A"
"Ear and labyrinth disorders",2019-10-09,2,0,0,0,"Group A"
"Ear and labyrinth disorders",2019-10-10,2,0,0,0,"Group A"
"Ear and labyrinth disorders",2019-10-11,18,0,0,0,"Group A"
"Ear and labyrinth disorders",2019-10-12,2,0,0,0,"Group A"
"Ear and labyrinth disorders",2019-10-13,14,0,0,0,"Group A"
"Ear and labyrinth disorders",2019-10-14,19,0,0,0,"Group A"
"Ear and labyrinth disorders",2019-10-15,9,0,0,0,"Group A"
"Ear and labyrinth disorders",2019-10-16,16,0,0,0,"Group A"
"Ear and labyrinth disorders",2019-10-17,9,0,0,0,"Group A"
"Endocrine disorders",2019-10-18,15,0,0,0,"Group A"
"Endocrine disorders",2019-10-19,17,0,0,0,"Group A"
"Endocrine disorders",2019-10-20,4,0,0,0,"Group A"
"Endocrine disorders",2019-10-21,9,0,0,0,"Group A"
"Endocrine disorders",2019-10-22,19,0,0,0,"Group A"
"Endocrine disorders",2019-10-23,18,0,0,0,"Group A"
"Endocrine disorders",2019-10-24,11,0,0,0,"Group A"
"Endocrine disorders",2019-10-25,2,0,0,0,"Group A"
"Endocrine disorders",2019-10-26,16,0,0,0,"Group A"
"Endocrine disorders",2019-10-27,14,0,0,0,"Group A"
"Endocrine disorders",2019-10-28,11,0,0,0,"Group A"
"Endocrine disorders",2019-10-29,2,0,0,0,"Group A"
"Endocrine disorders",2019-10-30,19,0,0,0,"Group A"
"Endocrine disorders",2019-10-31,19,0,0,0,"Group A"
"Endocrine disorders",2019-11-01,17,0,0,0,"Group A"
"Endocrine disorders",2019-11-02,15,0,0,0,"Group A"
"Endocrine disorders",2019-11-03,2,0,0,0,"Group A"
"Endocrine disorders",2019-11-04,18,0,0,0,"Group A"
"Eye disorders",2019-11-05,15,0,0,0,"Group A"
"Eye disorders",2019-11-06,17,0,0,0,"Group A"
"Eye disorders",2019-11-07,17,0,0,0,"Group A"
"Eye disorders",2019-11-08,17,0,0,0,"Group A"
"Eye disorders",2019-11-09,17,0,0,0,"Group A"
"Eye disorders",2019-11-10,15,0,0,0,"Group A"
"Eye disorders",2019-11-11,17,0,0,0,"Group A"
"Gastrointestinal disorders",2019-11-12,4,0,0,0,"Group A"
"Gastrointestinal disorders",2019-11-13,9,0,0,0,"Group A"
"Gastrointestinal disorders",2019-11-14,19,0,0,0,"Group A"
"Gastrointestinal disorders",2019-11-15,18,0,0,0,"Group A"
"Gastrointestinal disorders",2019-11-16,11,0,0,0,"Group A"
"Gastrointestinal disorders",2019-11-17,2,0,0,0,"Group A"
"Gastrointestinal disorders",2019-11-18,16,0,0,0,"Group A"
"Gastrointestinal disorders",2019-11-19,4,0,0,0,"Group A"
"Gastrointestinal disorders",2019-11-20,11,0,0,0,"Group A"
"Gastrointestinal disorders",2019-11-21,9,0,0,0,"Group A"
"Gastrointestinal disorders",2019-11-22,2,0,0,0,"Group A"
"General disorders and administration site conditions",2019-11-23,14,0,0,0,"Group A"
"General disorders and administration site conditions",2019-11-24,15,0,0,0,"Group A"
"General disorders and administration site conditions",2019-11-25,17,0,0,0,"Group A"
"General disorders and administration site conditions",2019-11-26,14,0,0,0,"Group A"
"General disorders and administration site conditions",2019-11-27,14,0,0,0,"Group A"
"General disorders and administration site conditions",2019-11-28,17,0,0,0,"Group A"
"Hepatobiliary disorders",2019-11-29,4,0,0,0,"Group A"
"Hepatobiliary disorders",2019-11-30,9,0,0,0,"Group A"
"Hepatobiliary disorders",2019-12-01,19,0,0,0,"Group A"
"Hepatobiliary disorders",2019-12-02,18,0,0,0,"Group A"
"Hepatobiliary disorders",2019-12-03,19,0,0,0,"Group A"
"Hepatobiliary disorders",2019-12-04,9,0,0,0,"Group A"
"Hepatobiliary disorders",2019-12-05,9,0,0,0,"Group A"
"Immune system disorders",2019-12-06,11,0,0,0,"Group A"
"Immune system disorders",2019-12-07,2,0,0,0,"Group A"
"Immune system disorders",2019-12-08,16,0,0,0,"Group A"
"Immune system disorders",2019-12-09,14,0,0,0,"Group A"
"Immune system disorders",2019-12-10,16,0,0,0,"Group A"
"Infections and infestations",2019-12-11,15,0,0,0,"Group A"
"Infections and infestations",2019-12-12,17,0,0,0,"Group A"
"Infections and infestations",2019-12-13,4,0,0,0,"Group A"
"Infections and infestations",2019-12-14,9,0,0,0,"Group A"
"Infections and infestations",2019-12-15,4,0,0,0,"Group A"
"Infections and infestations",2019-12-16,17,0,0,0,"Group A"
"Infections and infestations",2019-12-17,15,0,0,0,"Group A"
"Infections and infestations",2019-12-18,17,0,0,0,"Group A"
"Infections and infestations",2019-12-19,15,0,0,0,"Group A"
"Injury, poisoning and procedural complications",2019-12-20,19,0,0,0,"Group A"
"Injury, poisoning and procedural complications",2019-12-21,18,0,0,0,"Group A"
"Injury, poisoning and procedural complications",2019-12-22,11,0,0,0,"Group A"
"Injury, poisoning and procedural complications",2019-12-23,2,0,0,0,"Group A"
"Injury, poisoning and procedural complications",2019-12-24,16,0,0,0,"Group A"
"Injury, poisoning and procedural complications",2019-12-25,19,0,0,0,"Group A"
"Injury, poisoning and procedural complications",2019-12-26,2,0,0,0,"Group A"
"Injury, poisoning and procedural complications",2019-12-27,18,0,0,0,"Group A"
"Injury, poisoning and procedural complications",2019-12-28,16,0,0,0,"Group A"
"Investigations",2019-12-29,14,0,0,0,"Group A"
"Investigations",2019-12-30,15,0,0,0,"Group A"
"Investigations",2019-12-31,17,0,0,0,"Group A"
"Investigations",2020-01-01,4,0,0,0,"Group A"
"Investigations",2020-01-02,9,0,0,0,"Group A"
"Investigations",2020-01-03,19,0,0,0,"Group A"
"Investigations",2020-01-04,15,0,0,0,"Group A"
"Investigations",2020-01-05,9,0,0,0,"Group A"
"Metabolism and nutrition disorders",2020-01-06,18,0,0,0,"Group A"
"Metabolism and nutrition disorders",2020-01-07,11,0,0,0,"Group A"
"Metabolism and nutrition disorders",2020-01-08,2,0,0,0,"Group A"
"Metabolism and nutrition disorders",2020-01-09,16,0,0,0,"Group A"
"Metabolism and nutrition disorders",2020-01-10,14,0,0,0,"Group A"
"Metabolism and nutrition disorders",2020-01-11,15,0,0,0,"Group A"
"Metabolism and nutrition disorders",2020-01-12,18,0,0,0,"Group A"
"Metabolism and nutrition disorders",2020-01-13,14,0,0,0,"Group A"
"Metabolism and nutrition disorders",2020-01-14,18,0,0,0,"Group A"
"Metabolism and nutrition disorders",2020-01-15,16,0,0,0,"Group A"
"Metabolism and nutrition disorders",2020-01-16,18,0,0,0,"Group A"
"Metabolism and nutrition disorders",2020-01-17,18,0,0,0,"Group A"
"Metabolism and nutrition disorders",2020-01-18,2,0,0,0,"Group A"
"Metabolism and nutrition disorders",2020-01-19,18,0,0,0,"Group A"
"Musculoskeletal and connective tissue disorders",2020-01-20,17,0,0,0,"Group A"
"Musculoskeletal and connective tissue disorders",2020-01-21,4,0,0,0,"Group A"
"Musculoskeletal and connective tissue disorders",2020-01-22,9,0,0,0,"Group A"
"Musculoskeletal and connective tissue disorders",2020-01-23,19,0,0,0,"Group A"
"Musculoskeletal and connective tissue disorders",2020-01-24,4,0,0,0,"Group A"
"Musculoskeletal and connective tissue disorders",2020-01-25,19,0,0,0,"Group A"
"Musculoskeletal and connective tissue disorders",2020-01-26,4,0,0,0,"Group A"
"Musculoskeletal and connective tissue disorders",2020-01-27,9,0,0,0,"Group A"
"Musculoskeletal and connective tissue disorders",2020-01-28,9,0,0,0,"Group A"
"Musculoskeletal and connective tissue disorders",2020-01-29,4,0,0,0,"Group A"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2020-01-30,18,0,0,0,"Group A"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2020-01-31,11,0,0,0,"Group A"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2020-02-01,2,0,0,0,"Group A"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2020-02-02,16,0,0,0,"Group A"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2020-02-03,18,0,0,0,"Group A"
"Nervous system disorders",2020-02-04,14,0,0,0,"Group A"
"Nervous system disorders",2020-02-05,15,0,0,0,"Group A"
"Nervous system disorders",2020-02-06,17,0,0,0,"Group A"
"Nervous system disorders",2020-02-07,4,0,0,0,"Group A"
"Nervous system disorders",2020-02-08,9,0,0,0,"Group A"
"Nervous system disorders",2020-02-09,19,0,0,0,"Group A"
"Nervous system disorders",2020-02-10,18,0,0,0,"Group A"
"Nervous system disorders",2020-02-11,19,0,0,0,"Group A"
"Nervous system disorders",2020-02-12,14,0,0,0,"Group A"
"Nervous system disorders",2020-02-13,19,0,0,0,"Group A"
"Nervous system disorders",2020-02-14,19,0,0,0,"Group A"
"Nervous system disorders",2020-02-15,19,0,0,0,"Group A"
"Nervous system disorders",2020-02-16,18,0,0,0,"Group A"
"Nervous system disorders",2020-02-17,4,0,0,0,"Group A"
"Nervous system disorders",2020-02-18,9,0,0,0,"Group A"
"Nervous system disorders",2020-02-19,9,0,0,0,"Group A"
"Nervous system disorders",2020-02-20,18,0,0,0,"Group A"
"Pregnancy, puerperium and perinatal conditions",2020-02-21,11,0,0,0,"Group A"
"Pregnancy, puerperium and perinatal conditions",2020-02-22,2,0,0,0,"Group A"
"Pregnancy, puerperium and perinatal conditions",2020-02-23,16,0,0,0,"Group A"
"Pregnancy, puerperium and perinatal conditions",2020-02-24,14,0,0,0,"Group A"
"Pregnancy, puerperium and perinatal conditions",2020-02-25,2,0,0,0,"Group A"
"Pregnancy, puerperium and perinatal conditions",2020-02-26,2,0,0,0,"Group A"
"Pregnancy, puerperium and perinatal conditions",2020-02-27,2,0,0,0,"Group A"
"Psychiatric disorders",2020-02-28,15,0,0,0,"Group A"
"Psychiatric disorders",2020-02-29,17,0,0,0,"Group A"
"Psychiatric disorders",2020-03-01,4,0,0,0,"Group A"
"Psychiatric disorders",2020-03-02,9,0,0,0,"Group A"
"Psychiatric disorders",2020-03-03,19,0,0,0,"Group A"
"Renal and urinary disorders",2020-03-04,18,0,0,0,"Group A"
"Renal and urinary disorders",2020-03-05,11,0,0,0,"Group A"
"Renal and urinary disorders",2020-03-06,11,0,0,0,"Group A"
"Renal and urinary disorders",2020-03-07,11,0,0,0,"Group A"
"Renal and urinary disorders",2020-03-08,18,0,0,0,"Group A"
"Renal and urinary disorders",2020-03-09,18,0,0,0,"Group A"
"Renal and urinary disorders",2020-03-10,11,0,0,0,"Group A"
"Reproductive system and breast disorders",2020-03-11,2,0,0,0,"Group A"
"Reproductive system and breast disorders",2020-03-12,16,0,0,0,"Group A"
"Reproductive system and breast disorders",2020-03-13,14,0,0,0,"Group A"
"Reproductive system and breast disorders",2020-03-14,15,0,0,0,"Group A"
"Reproductive system and breast disorders",2020-03-15,17,0,0,0,"Group A"
"Reproductive system and breast disorders",2020-03-16,4,0,0,0,"Group A"
"Reproductive system and breast disorders",2020-03-17,9,0,0,0,"Group A"
"Reproductive system and breast disorders",2020-03-18,19,0,0,0,"Group A"
"Reproductive system and breast disorders",2020-03-19,16,0,0,0,"Group A"
"Reproductive system and breast disorders",2020-03-20,19,0,0,0,"Group A"
"Reproductive system and breast disorders",2020-03-21,9,0,0,0,"Group A"
"Reproductive system and breast disorders",2020-03-22,19,0,0,0,"Group A"
"Reproductive system and breast disorders",2020-03-23,16,0,0,0,"Group A"
"Reproductive system and breast disorders",2020-03-24,16,0,0,0,"Group A"
"Reproductive system and breast disorders",2020-03-25,9,0,0,0,"Group A"
"Reproductive system and breast disorders",2020-03-26,17,0,0,0,"Group A"
"Respiratory, thoracic and mediastinal disorders",2020-03-27,18,0,0,0,"Group A"
"Respiratory, thoracic and mediastinal disorders",2020-03-28,11,0,0,0,"Group A"
"Respiratory, thoracic and mediastinal disorders",2020-03-29,2,0,0,0,"Group A"
"Respiratory, thoracic and mediastinal disorders",2020-03-30,16,0,0,0,"Group A"
"Respiratory, thoracic and mediastinal disorders",2020-03-31,11,0,0,0,"Group A"
"Respiratory, thoracic and mediastinal disorders",2020-04-01,11,0,0,0,"Group A"
"Respiratory, thoracic and mediastinal disorders",2020-04-02,11,0,0,0,"Group A"
"Skin and subcutaneous tissue disorders",2020-04-03,14,0,0,0,"Group A"
"Skin and subcutaneous tissue disorders",2020-04-04,15,0,0,0,"Group A"
"Skin and subcutaneous tissue disorders",2020-04-05,17,0,0,0,"Group A"
"Skin and subcutaneous tissue disorders",2020-04-06,4,0,0,0,"Group A"
"Skin and subcutaneous tissue disorders",2020-04-07,4,0,0,0,"Group A"
"Social circumstances",2020-04-08,9,0,0,0,"Group A"
"Social circumstances",2020-04-09,19,0,0,0,"Group A"
"Social circumstances",2020-04-10,18,0,0,0,"Group A"
"Social circumstances",2020-04-11,11,0,0,0,"Group A"
"Social circumstances",2020-04-12,2,0,0,0,"Group A"
"Social circumstances",2020-04-13,16,0,0,0,"Group A"
"Social circumstances",2020-04-14,14,0,0,0,"Group A"
"Social circumstances",2020-04-15,15,0,0,0,"Group A"
"Social circumstances",2020-04-16,9,0,0,0,"Group A"
"Social circumstances",2020-04-17,11,0,0,0,"Group A"
"Social circumstances",2020-04-18,15,0,0,0,"Group A"
"Social circumstances",2020-04-19,2,0,0,0,"Group A"
"Social circumstances",2020-04-20,9,0,0,0,"Group A"
"Social circumstances",2020-04-21,14,0,0,0,"Group A"
"Surgical and medical procedures",2020-04-22,17,0,0,0,"Group A"
"Surgical and medical procedures",2020-04-23,4,0,0,0,"Group A"
"Surgical and medical procedures",2020-04-24,9,0,0,0,"Group A"
"Surgical and medical procedures",2020-04-25,19,0,0,0,"Group A"
"Surgical and medical procedures",2020-04-26,18,0,0,0,"Group A"
"Surgical and medical procedures",2020-04-27,11,0,0,0,"Group A"
"Surgical and medical procedures",2020-04-28,17,0,0,0,"Group A"
"Surgical and medical procedures",2020-04-29,4,0,0,0,"Group A"
"Surgical and medical procedures",2020-04-30,18,0,0,0,"Group A"
"Surgical and medical procedures",2020-05-01,19,0,0,0,"Group A"
"Surgical and medical procedures",2020-05-02,11,0,0,0,"Group A"
"Surgical and medical procedures",2020-05-03,9,0,0,0,"Group A"
"Surgical and medical procedures",2020-05-04,18,0,0,0,"Group A"
"Surgical and medical procedures",2020-05-05,17,0,0,0,"Group A"
"Surgical and medical procedures",2020-05-06,4,0,0,0,"Group A"
"Vascular disorders",2020-05-07,2,0,0,0,"Group A"
"Vascular disorders",2020-05-08,16,0,0,0,"Group A"
"Vascular disorders",2020-05-09,2,0,0,0,"Group A"
"Vascular disorders",2020-05-10,16,0,0,0,"Group A"
"Vascular disorders",2020-05-11,2,0,0,0,"Group A"
"Vascular disorders",2020-05-12,16,0,0,0,"Group A"
"Vascular disorders",2020-05-13,2,0,0,0,"Group A"
"Vascular disorders",2020-05-14,16,0,0,0,"Group A"
"Blood and lymphatic system disorders",2020-05-15,13,1,1,0,"Group A"
"Blood and lymphatic system disorders",2020-05-16,3,1,0,0,"Group A"
"Blood and lymphatic system disorders",2020-05-17,8,1,0,0,"Group A"
"Blood and lymphatic system disorders",2020-05-18,18,1,1,0,"Group A"
"Blood and lymphatic system disorders",2020-05-19,6,1,0,0,"Group A"
"Blood and lymphatic system disorders",2020-05-20,15,1,0,0,"Group A"
"Cardiac disorders",2020-05-21,1,1,0,0,"Group A"
"Cardiac disorders",2020-05-22,4,1,0,0,"Group A"
"Cardiac disorders",2020-05-23,14,1,1,0,"Group A"
"Cardiac disorders",2020-05-24,4,1,1,0,"Group A"
"Congenital, familial and genetic disorders",2020-05-25,16,1,1,0,"Group A"
"Congenital, familial and genetic disorders",2020-05-26,13,1,1,0,"Group A"
"Congenital, familial and genetic disorders",2020-05-27,3,1,0,0,"Group A"
"Congenital, familial and genetic disorders",2020-05-28,8,1,1,0,"Group A"
"Congenital, familial and genetic disorders",2020-05-29,18,1,1,0,"Group A"
"Ear and labyrinth disorders",2020-05-30,6,1,0,0,"Group A"
"Ear and labyrinth disorders",2020-05-31,15,1,0,0,"Group A"
"Ear and labyrinth disorders",2020-06-01,6,1,1,0,"Group A"
"Ear and labyrinth disorders",2020-06-02,6,1,1,0,"Group A"
"Ear and labyrinth disorders",2020-06-03,6,1,1,0,"Group A"
"Ear and labyrinth disorders",2020-06-04,15,1,0,0,"Group A"
"Ear and labyrinth disorders",2020-06-05,6,1,0,0,"Group A"
"Ear and labyrinth disorders",2020-06-06,6,1,1,0,"Group A"
"Ear and labyrinth disorders",2020-06-07,6,1,0,0,"Group A"
"Endocrine disorders",2020-06-08,1,1,0,0,"Group A"
"Endocrine disorders",2020-06-09,4,1,0,0,"Group A"
"Endocrine disorders",2020-06-10,14,1,1,0,"Group A"
"Endocrine disorders",2020-06-11,16,1,0,0,"Group A"
"Endocrine disorders",2020-06-12,13,1,0,0,"Group A"
"Endocrine disorders",2020-06-13,13,1,1,0,"Group A"
"Endocrine disorders",2020-06-14,4,1,1,0,"Group A"
"Endocrine disorders",2020-06-15,4,1,0,0,"Group A"
"Endocrine disorders",2020-06-16,4,1,1,0,"Group A"
"Endocrine disorders",2020-06-17,16,1,0,0,"Group A"
"Endocrine disorders",2020-06-18,14,1,0,0,"Group A"
"Endocrine disorders",2020-06-19,16,1,0,0,"Group A"
"Eye disorders",2020-06-20,3,1,0,0,"Group A"
"Eye disorders",2020-06-21,8,1,1,0,"Group A"
"Eye disorders",2020-06-22,18,1,0,0,"Group A"
"Eye disorders",2020-06-23,6,1,0,0,"Group A"
"Eye disorders",2020-06-24,15,1,1,0,"Group A"
"Eye disorders",2020-06-25,1,1,0,0,"Group A"
"Eye disorders",2020-06-26,8,1,0,0,"Group A"
"Eye disorders",2020-06-27,1,1,0,0,"Group A"
"Eye disorders",2020-06-28,1,1,0,0,"Group A"
"Eye disorders",2020-06-29,6,1,0,0,"Group A"
"Eye disorders",2020-06-30,3,1,1,0,"Group A"
"Eye disorders",2020-07-01,15,1,0,0,"Group A"
"Eye disorders",2020-07-02,8,1,0,0,"Group A"
"Eye disorders",2020-07-03,1,1,0,0,"Group A"
"Eye disorders",2020-07-04,8,1,1,0,"Group A"
"Eye disorders",2020-07-05,6,1,0,0,"Group A"
"Gastrointestinal disorders",2020-07-06,14,1,0,1,"Group A"
"Gastrointestinal disorders",2020-07-07,4,1,1,0,"Group A"
"Gastrointestinal disorders",2020-07-08,16,1,0,0,"Group A"
"Gastrointestinal disorders",2020-07-09,13,1,0,0,"Group A"
"Gastrointestinal disorders",2020-07-10,3,1,1,0,"Group A"
"Gastrointestinal disorders",2020-07-11,8,1,0,0,"Group A"
"Gastrointestinal disorders",2020-07-12,18,1,0,0,"Group A"
"Gastrointestinal disorders",2020-07-13,13,1,0,0,"Group A"
"General disorders and administration site conditions",2020-07-14,6,1,0,0,"Group A"
"General disorders and administration site conditions",2020-07-15,15,1,0,0,"Group A"
"General disorders and administration site conditions",2020-07-16,1,1,1,0,"Group A"
"General disorders and administration site conditions",2020-07-17,4,1,0,0,"Group A"
"General disorders and administration site conditions",2020-07-18,14,1,1,0,"Group A"
"General disorders and administration site conditions",2020-07-19,16,1,1,0,"Group A"
"General disorders and administration site conditions",2020-07-20,13,1,1,0,"Group A"
"General disorders and administration site conditions",2020-07-21,3,1,0,0,"Group A"
"General disorders and administration site conditions",2020-07-22,8,1,0,0,"Group A"
"General disorders and administration site conditions",2020-07-23,18,1,0,0,"Group A"
"General disorders and administration site conditions",2020-07-24,16,1,1,0,"Group A"
"General disorders and administration site conditions",2020-07-25,1,1,1,0,"Group A"
"General disorders and administration site conditions",2020-07-26,8,1,1,0,"Group A"
"General disorders and administration site conditions",2020-07-27,16,1,1,0,"Group A"
"General disorders and administration site conditions",2020-07-28,1,1,1,0,"Group A"
"General disorders and administration site conditions",2020-07-29,8,1,1,0,"Group A"
"General disorders and administration site conditions",2020-07-30,18,1,1,0,"Group A"
"General disorders and administration site conditions",2020-07-31,4,1,0,0,"Group A"
"General disorders and administration site conditions",2020-08-01,15,1,0,0,"Group A"
"General disorders and administration site conditions",2020-08-02,15,1,1,0,"Group A"
"Hepatobiliary disorders",2020-08-03,6,1,0,0,"Group A"
"Hepatobiliary disorders",2020-08-04,15,1,0,0,"Group A"
"Hepatobiliary disorders",2020-08-05,1,1,1,0,"Group A"
"Hepatobiliary disorders",2020-08-06,4,1,0,0,"Group A"
"Hepatobiliary disorders",2020-08-07,14,1,0,0,"Group A"
"Immune system disorders",2020-08-08,16,1,1,0,"Group A"
"Immune system disorders",2020-08-09,13,1,0,0,"Group A"
"Immune system disorders",2020-08-10,3,1,1,0,"Group A"
"Immune system disorders",2020-08-11,8,1,0,0,"Group A"
"Immune system disorders",2020-08-12,18,1,0,0,"Group A"
"Immune system disorders",2020-08-13,6,1,0,0,"Group A"
"Immune system disorders",2020-08-14,15,1,0,0,"Group A"
"Immune system disorders",2020-08-15,8,1,0,0,"Group A"
"Immune system disorders",2020-08-16,8,1,1,0,"Group A"
"Immune system disorders",2020-08-17,16,1,0,0,"Group A"
"Infections and infestations",2020-08-18,1,1,1,0,"Group A"
"Infections and infestations",2020-08-19,4,1,0,0,"Group A"
"Infections and infestations",2020-08-20,14,1,0,0,"Group A"
"Infections and infestations",2020-08-21,14,1,0,0,"Group A"
"Infections and infestations",2020-08-22,1,1,1,0,"Group A"
"Infections and infestations",2020-08-23,4,1,1,0,"Group A"
"Infections and infestations",2020-08-24,4,1,0,0,"Group A"
"Injury, poisoning and procedural complications",2020-08-25,16,1,1,0,"Group A"
"Injury, poisoning and procedural complications",2020-08-26,13,1,1,0,"Group A"
"Injury, poisoning and procedural complications",2020-08-27,3,1,1,0,"Group A"
"Injury, poisoning and procedural complications",2020-08-28,8,1,1,0,"Group A"
"Injury, poisoning and procedural complications",2020-08-29,18,1,0,0,"Group A"
"Injury, poisoning and procedural complications",2020-08-30,18,1,1,0,"Group A"
"Investigations",2020-08-31,8,1,1,1,"Group A"
"Investigations",2020-09-01,15,1,0,0,"Group A"
"Investigations",2020-09-02,1,1,1,0,"Group A"
"Investigations",2020-09-03,4,1,0,0,"Group A"
"Investigations",2020-09-04,4,1,1,0,"Group A"
"Investigations",2020-09-05,1,1,1,0,"Group A"
"Investigations",2020-09-06,15,1,0,0,"Group A"
"Investigations",2020-09-07,1,1,0,0,"Group A"
"Metabolism and nutrition disorders",2020-09-08,4,1,0,0,"Group A"
"Metabolism and nutrition disorders",2020-09-09,14,1,0,0,"Group A"
"Metabolism and nutrition disorders",2020-09-10,16,1,1,0,"Group A"
"Metabolism and nutrition disorders",2020-09-11,13,1,0,0,"Group A"
"Metabolism and nutrition disorders",2020-09-12,3,1,1,0,"Group A"
"Metabolism and nutrition disorders",2020-09-13,8,1,0,0,"Group A"
"Metabolism and nutrition disorders",2020-09-14,18,1,0,0,"Group A"
"Metabolism and nutrition disorders",2020-09-15,6,1,0,0,"Group A"
"Metabolism and nutrition disorders",2020-09-16,4,1,0,0,"Group A"
"Metabolism and nutrition disorders",2020-09-17,16,1,0,0,"Group A"
"Musculoskeletal and connective tissue disorders",2020-09-18,4,1,0,1,"Group A"
"Musculoskeletal and connective tissue disorders",2020-09-19,15,1,1,0,"Group A"
"Musculoskeletal and connective tissue disorders",2020-09-20,1,1,0,0,"Group A"
"Musculoskeletal and connective tissue disorders",2020-09-21,14,1,1,0,"Group A"
"Musculoskeletal and connective tissue disorders",2020-09-22,16,1,0,0,"Group A"
"Musculoskeletal and connective tissue disorders",2020-09-23,14,1,1,0,"Group A"
"Musculoskeletal and connective tissue disorders",2020-09-24,15,1,1,0,"Group A"
"Musculoskeletal and connective tissue disorders",2020-09-25,16,1,0,0,"Group A"
"Musculoskeletal and connective tissue disorders",2020-09-26,4,1,0,0,"Group A"
"Musculoskeletal and connective tissue disorders",2020-09-27,16,1,0,0,"Group A"
"Musculoskeletal and connective tissue disorders",2020-09-28,15,1,0,0,"Group A"
"Musculoskeletal and connective tissue disorders",2020-09-29,4,1,0,0,"Group A"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2020-09-30,16,1,0,0,"Group A"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2020-10-01,13,1,1,0,"Group A"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2020-10-02,3,1,0,0,"Group A"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2020-10-03,8,1,1,0,"Group A"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2020-10-04,18,1,1,0,"Group A"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2020-10-05,8,1,0,0,"Group A"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2020-10-06,3,1,1,0,"Group A"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2020-10-07,13,1,1,0,"Group A"
"Nervous system disorders",2020-10-08,6,1,0,0,"Group A"
"Nervous system disorders",2020-10-09,15,1,1,0,"Group A"
"Nervous system disorders",2020-10-10,1,1,1,0,"Group A"
"Nervous system disorders",2020-10-11,4,1,1,0,"Group A"
"Nervous system disorders",2020-10-12,14,1,0,0,"Group A"
"Nervous system disorders",2020-10-13,4,1,1,0,"Group A"
"Nervous system disorders",2020-10-14,6,1,1,0,"Group A"
"Nervous system disorders",2020-10-15,15,1,0,0,"Group A"
"Pregnancy, puerperium and perinatal conditions",2020-10-16,16,1,0,0,"Group A"
"Pregnancy, puerperium and perinatal conditions",2020-10-17,13,1,1,0,"Group A"
"Pregnancy, puerperium and perinatal conditions",2020-10-18,3,1,1,0,"Group A"
"Pregnancy, puerperium and perinatal conditions",2020-10-19,3,1,0,0,"Group A"
"Pregnancy, puerperium and perinatal conditions",2020-10-20,13,1,1,0,"Group A"
"Pregnancy, puerperium and perinatal conditions",2020-10-21,13,1,1,0,"Group A"
"Pregnancy, puerperium and perinatal conditions",2020-10-22,16,1,0,0,"Group A"
"Psychiatric disorders",2020-10-23,8,1,0,0,"Group A"
"Psychiatric disorders",2020-10-24,18,1,1,0,"Group A"
"Psychiatric disorders",2020-10-25,6,1,0,0,"Group A"
"Psychiatric disorders",2020-10-26,15,1,1,0,"Group A"
"Psychiatric disorders",2020-10-27,1,1,1,0,"Group A"
"Psychiatric disorders",2020-10-28,4,1,0,0,"Group A"
"Psychiatric disorders",2020-10-29,1,1,1,0,"Group A"
"Psychiatric disorders",2020-10-30,15,1,0,0,"Group A"
"Renal and urinary disorders",2020-10-31,14,1,0,0,"Group A"
"Renal and urinary disorders",2020-11-01,16,1,1,0,"Group A"
"Renal and urinary disorders",2020-11-02,13,1,1,0,"Group A"
"Renal and urinary disorders",2020-11-03,3,1,1,0,"Group A"
"Renal and urinary disorders",2020-11-04,16,1,0,0,"Group A"
"Reproductive system and breast disorders",2020-11-05,8,1,1,0,"Group A"
"Reproductive system and breast disorders",2020-11-06,18,1,0,0,"Group A"
"Reproductive system and breast disorders",2020-11-07,6,1,1,0,"Group A"
"Reproductive system and breast disorders",2020-11-08,15,1,1,0,"Group A"
"Reproductive system and breast disorders",2020-11-09,1,1,1,0,"Group A"
"Reproductive system and breast disorders",2020-11-10,1,1,0,0,"Group A"
"Reproductive system and breast disorders",2020-11-11,1,1,0,0,"Group A"
"Reproductive system and breast disorders",2020-11-12,6,1,1,0,"Group A"
"Reproductive system and breast disorders",2020-11-13,18,1,0,0,"Group A"
"Reproductive system and breast disorders",2020-11-14,8,1,0,0,"Group A"
"Reproductive system and breast disorders",2020-11-15,8,1,1,0,"Group A"
"Respiratory, thoracic and mediastinal disorders",2020-11-16,4,1,0,0,"Group A"
"Respiratory, thoracic and mediastinal disorders",2020-11-17,14,1,0,0,"Group A"
"Respiratory, thoracic and mediastinal disorders",2020-11-18,16,1,1,0,"Group A"
"Respiratory, thoracic and mediastinal disorders",2020-11-19,13,1,1,0,"Group A"
"Respiratory, thoracic and mediastinal disorders",2020-11-20,3,1,0,0,"Group A"
"Respiratory, thoracic and mediastinal disorders",2020-11-21,8,1,1,0,"Group A"
"Respiratory, thoracic and mediastinal disorders",2020-11-22,18,1,0,0,"Group A"
"Respiratory, thoracic and mediastinal disorders",2020-11-23,18,1,1,0,"Group A"
"Respiratory, thoracic and mediastinal disorders",2020-11-24,4,1,1,0,"Group A"
"Respiratory, thoracic and mediastinal disorders",2020-11-25,16,1,1,0,"Group A"
"Respiratory, thoracic and mediastinal disorders",2020-11-26,14,1,1,0,"Group A"
"Respiratory, thoracic and mediastinal disorders",2020-11-27,8,1,1,0,"Group A"
"Respiratory, thoracic and mediastinal disorders",2020-11-28,14,1,1,0,"Group A"
"Respiratory, thoracic and mediastinal disorders",2020-11-29,18,1,0,0,"Group A"
"Respiratory, thoracic and mediastinal disorders",2020-11-30,14,1,1,0,"Group A"
"Respiratory, thoracic and mediastinal disorders",2020-12-01,8,1,0,0,"Group A"
"Respiratory, thoracic and mediastinal disorders",2020-12-02,18,1,0,0,"Group A"
"Skin and subcutaneous tissue disorders",2020-12-03,6,1,0,0,"Group A"
"Skin and subcutaneous tissue disorders",2020-12-04,15,1,1,0,"Group A"
"Skin and subcutaneous tissue disorders",2020-12-05,1,1,0,0,"Group A"
"Skin and subcutaneous tissue disorders",2020-12-06,15,1,0,0,"Group A"
"Skin and subcutaneous tissue disorders",2020-12-07,1,1,0,0,"Group A"
"Skin and subcutaneous tissue disorders",2020-12-08,6,1,1,0,"Group A"
"Social circumstances",2020-12-09,4,1,1,0,"Group A"
"Social circumstances",2020-12-10,14,1,1,0,"Group A"
"Social circumstances",2020-12-11,16,1,0,0,"Group A"
"Social circumstances",2020-12-12,13,1,1,0,"Group A"
"Social circumstances",2020-12-13,3,1,0,0,"Group A"
"Social circumstances",2020-12-14,8,1,0,0,"Group A"
"Social circumstances",2020-12-15,18,1,0,0,"Group A"
"Social circumstances",2020-12-16,6,1,0,0,"Group A"
"Social circumstances",2020-12-17,4,1,1,0,"Group A"
"Social circumstances",2020-12-18,14,1,0,0,"Group A"
"Social circumstances",2020-12-19,3,1,0,0,"Group A"
"Social circumstances",2020-12-20,18,1,1,0,"Group A"
"Surgical and medical procedures",2020-12-21,15,1,1,0,"Group A"
"Surgical and medical procedures",2020-12-22,1,1,1,0,"Group A"
"Surgical and medical procedures",2020-12-23,4,1,0,0,"Group A"
"Surgical and medical procedures",2020-12-24,14,1,0,0,"Group A"
"Surgical and medical procedures",2020-12-25,16,1,1,0,"Group A"
"Vascular disorders",2020-12-26,13,1,1,0,"Group A"
"Vascular disorders",2020-12-27,3,1,1,0,"Group A"
"Vascular disorders",2020-12-28,8,1,0,0,"Group A"
"Vascular disorders",2020-12-29,18,1,1,0,"Group A"
"Vascular disorders",2020-12-30,13,1,1,0,"Group A"
"Vascular disorders",2020-12-31,8,1,0,0,"Group A"
"Vascular disorders",2021-01-01,8,1,0,0,"Group A"
"Vascular disorders",2021-01-02,13,1,1,0,"Group A"
"Vascular disorders",2021-01-03,13,1,1,0,"Group A"
"Vascular disorders",2021-01-04,18,1,1,0,"Group A"
"Vascular disorders",2021-01-05,18,1,1,0,"Group A"
"Vascular disorders",2021-01-06,13,1,0,0,"Group A"
"Blood and lymphatic system disorders",2021-01-07,29,0,0,0,"Group B"
"Blood and lymphatic system disorders",2021-01-08,39,0,0,0,"Group B"
"Blood and lymphatic system disorders",2021-01-09,26,0,0,0,"Group B"
"Blood and lymphatic system disorders",2021-01-10,27,0,0,0,"Group B"
"Blood and lymphatic system disorders",2021-01-11,38,0,0,0,"Group B"
"Blood and lymphatic system disorders",2021-01-12,35,0,0,0,"Group B"
"Blood and lymphatic system disorders",2021-01-13,38,0,0,0,"Group B"
"Blood and lymphatic system disorders",2021-01-14,38,0,0,0,"Group B"
"Blood and lymphatic system disorders",2021-01-15,27,0,0,0,"Group B"
"Blood and lymphatic system disorders",2021-01-16,26,0,0,0,"Group B"
"Blood and lymphatic system disorders",2021-01-17,26,0,0,0,"Group B"
"Blood and lymphatic system disorders",2021-01-18,35,0,0,0,"Group B"
"Blood and lymphatic system disorders",2021-01-19,39,0,0,0,"Group B"
"Blood and lymphatic system disorders",2021-01-20,35,0,0,0,"Group B"
"Cardiac disorders",2021-01-21,34,0,0,0,"Group B"
"Cardiac disorders",2021-01-22,21,0,0,0,"Group B"
"Cardiac disorders",2021-01-23,32,0,0,0,"Group B"
"Cardiac disorders",2021-01-24,42,0,0,0,"Group B"
"Cardiac disorders",2021-01-25,36,0,0,0,"Group B"
"Cardiac disorders",2021-01-26,37,0,0,0,"Group B"
"Cardiac disorders",2021-01-27,24,0,0,0,"Group B"
"Cardiac disorders",2021-01-28,31,0,0,0,"Group B"
"Cardiac disorders",2021-01-29,29,0,0,0,"Group B"
"Cardiac disorders",2021-01-30,39,0,0,0,"Group B"
"Cardiac disorders",2021-01-31,26,0,0,0,"Group B"
"Cardiac disorders",2021-02-01,26,0,0,0,"Group B"
"Cardiac disorders",2021-02-02,29,0,0,0,"Group B"
"Cardiac disorders",2021-02-03,31,0,0,0,"Group B"
"Cardiac disorders",2021-02-04,34,0,0,0,"Group B"
"Congenital, familial and genetic disorders",2021-02-05,27,0,0,0,"Group B"
"Congenital, familial and genetic disorders",2021-02-06,38,0,0,0,"Group B"
"Congenital, familial and genetic disorders",2021-02-07,35,0,0,0,"Group B"
"Congenital, familial and genetic disorders",2021-02-08,34,0,0,0,"Group B"
"Congenital, familial and genetic disorders",2021-02-09,21,0,0,0,"Group B"
"Congenital, familial and genetic disorders",2021-02-10,32,0,0,0,"Group B"
"Congenital, familial and genetic disorders",2021-02-11,32,0,0,0,"Group B"
"Congenital, familial and genetic disorders",2021-02-12,21,0,0,0,"Group B"
"Congenital, familial and genetic disorders",2021-02-13,21,0,0,0,"Group B"
"Congenital, familial and genetic disorders",2021-02-14,35,0,0,0,"Group B"
"Congenital, familial and genetic disorders",2021-02-15,21,0,0,0,"Group B"
"Ear and labyrinth disorders",2021-02-16,42,0,0,0,"Group B"
"Ear and labyrinth disorders",2021-02-17,36,0,0,0,"Group B"
"Ear and labyrinth disorders",2021-02-18,37,0,0,0,"Group B"
"Ear and labyrinth disorders",2021-02-19,24,0,0,0,"Group B"
"Ear and labyrinth disorders",2021-02-20,31,0,0,0,"Group B"
"Ear and labyrinth disorders",2021-02-21,29,0,0,0,"Group B"
"Ear and labyrinth disorders",2021-02-22,39,0,0,0,"Group B"
"Ear and labyrinth disorders",2021-02-23,37,0,0,0,"Group B"
"Ear and labyrinth disorders",2021-02-24,37,0,0,0,"Group B"
"Ear and labyrinth disorders",2021-02-25,39,0,0,0,"Group B"
"Ear and labyrinth disorders",2021-02-26,31,0,0,0,"Group B"
"Ear and labyrinth disorders",2021-02-27,39,0,0,0,"Group B"
"Ear and labyrinth disorders",2021-02-28,37,0,0,0,"Group B"
"Ear and labyrinth disorders",2021-03-01,37,0,0,0,"Group B"
"Ear and labyrinth disorders",2021-03-02,29,0,0,0,"Group B"
"Ear and labyrinth disorders",2021-03-03,39,0,0,0,"Group B"
"Endocrine disorders",2021-03-04,26,0,0,0,"Group B"
"Endocrine disorders",2021-03-05,27,0,0,0,"Group B"
"Endocrine disorders",2021-03-06,38,0,0,0,"Group B"
"Endocrine disorders",2021-03-07,35,0,0,0,"Group B"
"Endocrine disorders",2021-03-08,34,0,0,0,"Group B"
"Endocrine disorders",2021-03-09,26,0,0,0,"Group B"
"Endocrine disorders",2021-03-10,35,0,0,0,"Group B"
"Endocrine disorders",2021-03-11,34,0,0,0,"Group B"
"Endocrine disorders",2021-03-12,38,0,0,0,"Group B"
"Endocrine disorders",2021-03-13,38,0,0,0,"Group B"
"Endocrine disorders",2021-03-14,38,0,0,0,"Group B"
"Eye disorders",2021-03-15,21,0,0,0,"Group B"
"Eye disorders",2021-03-16,32,0,0,0,"Group B"
"Eye disorders",2021-03-17,42,0,0,0,"Group B"
"Eye disorders",2021-03-18,36,0,0,0,"Group B"
"Eye disorders",2021-03-19,37,0,0,0,"Group B"
"Eye disorders",2021-03-20,24,0,0,0,"Group B"
"Eye disorders",2021-03-21,32,0,0,0,"Group B"
"Eye disorders",2021-03-22,36,0,0,0,"Group B"
"Eye disorders",2021-03-23,24,0,0,0,"Group B"
"Gastrointestinal disorders",2021-03-24,31,0,0,0,"Group B"
"Gastrointestinal disorders",2021-03-25,29,0,0,0,"Group B"
"Gastrointestinal disorders",2021-03-26,39,0,0,0,"Group B"
"Gastrointestinal disorders",2021-03-27,26,0,0,0,"Group B"
"Gastrointestinal disorders",2021-03-28,27,0,0,0,"Group B"
"Gastrointestinal disorders",2021-03-29,38,0,0,0,"Group B"
"Gastrointestinal disorders",2021-03-30,35,0,0,0,"Group B"
"Gastrointestinal disorders",2021-03-31,34,0,0,0,"Group B"
"Gastrointestinal disorders",2021-04-01,29,0,0,0,"Group B"
"Gastrointestinal disorders",2021-04-02,26,0,0,0,"Group B"
"Gastrointestinal disorders",2021-04-03,35,0,0,0,"Group B"
"Gastrointestinal disorders",2021-04-04,39,0,0,0,"Group B"
"Gastrointestinal disorders",2021-04-05,34,0,0,0,"Group B"
"Gastrointestinal disorders",2021-04-06,34,0,0,0,"Group B"
"Gastrointestinal disorders",2021-04-07,26,0,0,0,"Group B"
"Gastrointestinal disorders",2021-04-08,27,0,0,0,"Group B"
"General disorders and administration site conditions",2021-04-09,21,0,0,0,"Group B"
"General disorders and administration site conditions",2021-04-10,32,0,0,0,"Group B"
"General disorders and administration site conditions",2021-04-11,42,0,0,0,"Group B"
"General disorders and administration site conditions",2021-04-12,36,0,0,0,"Group B"
"General disorders and administration site conditions",2021-04-13,37,0,0,0,"Group B"
"General disorders and administration site conditions",2021-04-14,36,0,0,0,"Group B"
"General disorders and administration site conditions",2021-04-15,42,0,0,0,"Group B"
"General disorders and administration site conditions",2021-04-16,32,0,0,0,"Group B"
"Hepatobiliary disorders",2021-04-17,24,0,0,0,"Group B"
"Hepatobiliary disorders",2021-04-18,31,0,0,0,"Group B"
"Hepatobiliary disorders",2021-04-19,29,0,0,0,"Group B"
"Hepatobiliary disorders",2021-04-20,39,0,0,0,"Group B"
"Hepatobiliary disorders",2021-04-21,26,0,0,0,"Group B"
"Hepatobiliary disorders",2021-04-22,27,0,0,0,"Group B"
"Hepatobiliary disorders",2021-04-23,38,0,0,0,"Group B"
"Hepatobiliary disorders",2021-04-24,35,0,0,0,"Group B"
"Hepatobiliary disorders",2021-04-25,29,0,0,0,"Group B"
"Hepatobiliary disorders",2021-04-26,27,0,0,0,"Group B"
"Hepatobiliary disorders",2021-04-27,31,0,0,0,"Group B"
"Hepatobiliary disorders",2021-04-28,39,0,0,0,"Group B"
"Hepatobiliary disorders",2021-04-29,31,0,0,0,"Group B"
"Hepatobiliary disorders",2021-04-30,26,0,0,0,"Group B"
"Hepatobiliary disorders",2021-05-01,27,0,0,0,"Group B"
"Hepatobiliary disorders",2021-05-02,38,0,0,0,"Group B"
"Immune system disorders",2021-05-03,34,0,0,0,"Group B"
"Immune system disorders",2021-05-04,21,0,0,0,"Group B"
"Immune system disorders",2021-05-05,32,0,0,0,"Group B"
"Immune system disorders",2021-05-06,42,0,0,0,"Group B"
"Immune system disorders",2021-05-07,36,0,0,0,"Group B"
"Immune system disorders",2021-05-08,37,0,0,0,"Group B"
"Immune system disorders",2021-05-09,24,0,0,0,"Group B"
"Immune system disorders",2021-05-10,31,0,0,0,"Group B"
"Immune system disorders",2021-05-11,29,0,0,0,"Group B"
"Immune system disorders",2021-05-12,34,0,0,0,"Group B"
"Immune system disorders",2021-05-13,36,0,0,0,"Group B"
"Immune system disorders",2021-05-14,34,0,0,0,"Group B"
"Immune system disorders",2021-05-15,32,0,0,0,"Group B"
"Immune system disorders",2021-05-16,36,0,0,0,"Group B"
"Immune system disorders",2021-05-17,37,0,0,0,"Group B"
"Immune system disorders",2021-05-18,34,0,0,0,"Group B"
"Immune system disorders",2021-05-19,31,0,0,0,"Group B"
"Infections and infestations",2021-05-20,39,0,0,0,"Group B"
"Infections and infestations",2021-05-21,26,0,0,0,"Group B"
"Infections and infestations",2021-05-22,27,0,0,0,"Group B"
"Infections and infestations",2021-05-23,38,0,0,0,"Group B"
"Infections and infestations",2021-05-24,26,0,0,0,"Group B"
"Infections and infestations",2021-05-25,39,0,0,0,"Group B"
"Infections and infestations",2021-05-26,39,0,0,0,"Group B"
"Infections and infestations",2021-05-27,26,0,0,0,"Group B"
"Infections and infestations",2021-05-28,26,0,0,0,"Group B"
"Infections and infestations",2021-05-29,27,0,0,0,"Group B"
"Infections and infestations",2021-05-30,26,0,0,0,"Group B"
"Infections and infestations",2021-05-31,27,0,0,0,"Group B"
"Infections and infestations",2021-06-01,27,0,0,0,"Group B"
"Infections and infestations",2021-06-02,38,0,0,0,"Group B"
"Injury, poisoning and procedural complications",2021-06-03,35,0,0,0,"Group B"
"Injury, poisoning and procedural complications",2021-06-04,34,0,0,0,"Group B"
"Injury, poisoning and procedural complications",2021-06-05,21,0,0,0,"Group B"
"Injury, poisoning and procedural complications",2021-06-06,32,0,0,0,"Group B"
"Injury, poisoning and procedural complications",2021-06-07,21,0,0,0,"Group B"
"Injury, poisoning and procedural complications",2021-06-08,21,0,0,0,"Group B"
"Injury, poisoning and procedural complications",2021-06-09,32,0,0,0,"Group B"
"Injury, poisoning and procedural complications",2021-06-10,32,0,0,0,"Group B"
"Injury, poisoning and procedural complications",2021-06-11,32,0,0,0,"Group B"
"Injury, poisoning and procedural complications",2021-06-12,34,0,0,0,"Group B"
"Injury, poisoning and procedural complications",2021-06-13,34,0,0,0,"Group B"
"Injury, poisoning and procedural complications",2021-06-14,35,0,0,0,"Group B"
"Injury, poisoning and procedural complications",2021-06-15,35,0,0,0,"Group B"
"Injury, poisoning and procedural complications",2021-06-16,32,0,0,0,"Group B"
"Investigations",2021-06-17,42,0,0,0,"Group B"
"Investigations",2021-06-18,36,0,0,0,"Group B"
"Investigations",2021-06-19,37,0,0,0,"Group B"
"Investigations",2021-06-20,24,0,0,0,"Group B"
"Investigations",2021-06-21,31,0,0,0,"Group B"
"Investigations",2021-06-22,29,0,0,0,"Group B"
"Investigations",2021-06-23,31,0,0,0,"Group B"
"Investigations",2021-06-24,31,0,0,0,"Group B"
"Investigations",2021-06-25,42,0,0,0,"Group B"
"Investigations",2021-06-26,29,0,0,0,"Group B"
"Investigations",2021-06-27,36,0,0,0,"Group B"
"Investigations",2021-06-28,36,0,0,0,"Group B"
"Investigations",2021-06-29,29,0,0,0,"Group B"
"Investigations",2021-06-30,42,0,0,0,"Group B"
"Metabolism and nutrition disorders",2021-07-01,39,0,0,0,"Group B"
"Metabolism and nutrition disorders",2021-07-02,26,0,0,0,"Group B"
"Metabolism and nutrition disorders",2021-07-03,27,0,0,0,"Group B"
"Metabolism and nutrition disorders",2021-07-04,38,0,0,0,"Group B"
"Metabolism and nutrition disorders",2021-07-05,35,0,0,0,"Group B"
"Metabolism and nutrition disorders",2021-07-06,35,0,0,0,"Group B"
"Metabolism and nutrition disorders",2021-07-07,26,0,0,0,"Group B"
"Metabolism and nutrition disorders",2021-07-08,27,0,0,0,"Group B"
"Musculoskeletal and connective tissue disorders",2021-07-09,34,0,0,0,"Group B"
"Musculoskeletal and connective tissue disorders",2021-07-10,21,0,0,0,"Group B"
"Musculoskeletal and connective tissue disorders",2021-07-11,32,0,0,0,"Group B"
"Musculoskeletal and connective tissue disorders",2021-07-12,34,0,0,0,"Group B"
"Musculoskeletal and connective tissue disorders",2021-07-13,34,0,0,0,"Group B"
"Musculoskeletal and connective tissue disorders",2021-07-14,34,0,0,0,"Group B"
"Musculoskeletal and connective tissue disorders",2021-07-15,34,0,0,0,"Group B"
"Musculoskeletal and connective tissue disorders",2021-07-16,21,0,0,0,"Group B"
"Musculoskeletal and connective tissue disorders",2021-07-17,21,0,0,0,"Group B"
"Musculoskeletal and connective tissue disorders",2021-07-18,34,0,0,0,"Group B"
"Musculoskeletal and connective tissue disorders",2021-07-19,34,0,0,0,"Group B"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2021-07-20,42,0,0,0,"Group B"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2021-07-21,36,0,0,0,"Group B"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2021-07-22,37,0,0,0,"Group B"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2021-07-23,24,0,0,0,"Group B"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2021-07-24,36,0,0,0,"Group B"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2021-07-25,36,0,0,0,"Group B"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2021-07-26,37,0,0,0,"Group B"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2021-07-27,42,0,0,0,"Group B"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2021-07-28,24,0,0,0,"Group B"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2021-07-29,37,0,0,0,"Group B"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2021-07-30,42,0,0,0,"Group B"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2021-07-31,24,0,0,0,"Group B"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2021-08-01,24,0,0,0,"Group B"
"Nervous system disorders",2021-08-02,31,0,0,0,"Group B"
"Nervous system disorders",2021-08-03,29,0,0,0,"Group B"
"Nervous system disorders",2021-08-04,39,0,0,0,"Group B"
"Nervous system disorders",2021-08-05,26,0,0,0,"Group B"
"Nervous system disorders",2021-08-06,27,0,0,0,"Group B"
"Nervous system disorders",2021-08-07,38,0,0,0,"Group B"
"Nervous system disorders",2021-08-08,35,0,0,0,"Group B"
"Nervous system disorders",2021-08-09,34,0,0,0,"Group B"
"Nervous system disorders",2021-08-10,27,0,0,0,"Group B"
"Nervous system disorders",2021-08-11,38,0,0,0,"Group B"
"Nervous system disorders",2021-08-12,39,0,0,0,"Group B"
"Pregnancy, puerperium and perinatal conditions",2021-08-13,21,0,0,0,"Group B"
"Pregnancy, puerperium and perinatal conditions",2021-08-14,32,0,0,0,"Group B"
"Pregnancy, puerperium and perinatal conditions",2021-08-15,42,0,0,0,"Group B"
"Pregnancy, puerperium and perinatal conditions",2021-08-16,36,0,0,0,"Group B"
"Pregnancy, puerperium and perinatal conditions",2021-08-17,37,0,0,0,"Group B"
"Pregnancy, puerperium and perinatal conditions",2021-08-18,24,0,0,0,"Group B"
"Pregnancy, puerperium and perinatal conditions",2021-08-19,31,0,0,0,"Group B"
"Pregnancy, puerperium and perinatal conditions",2021-08-20,29,0,0,0,"Group B"
"Pregnancy, puerperium and perinatal conditions",2021-08-21,39,0,0,0,"Group B"
"Pregnancy, puerperium and perinatal conditions",2021-08-22,26,0,0,0,"Group B"
"Pregnancy, puerperium and perinatal conditions",2021-08-23,27,0,0,0,"Group B"
"Pregnancy, puerperium and perinatal conditions",2021-08-24,38,0,0,0,"Group B"
"Pregnancy, puerperium and perinatal conditions",2021-08-25,35,0,0,0,"Group B"
"Pregnancy, puerperium and perinatal conditions",2021-08-26,34,0,0,0,"Group B"
"Pregnancy, puerperium and perinatal conditions",2021-08-27,26,0,0,0,"Group B"
"Pregnancy, puerperium and perinatal conditions",2021-08-28,35,0,0,0,"Group B"
"Pregnancy, puerperium and perinatal conditions",2021-08-29,31,0,0,0,"Group B"
"Pregnancy, puerperium and perinatal conditions",2021-08-30,26,0,0,0,"Group B"
"Pregnancy, puerperium and perinatal conditions",2021-08-31,38,0,0,0,"Group B"
"Pregnancy, puerperium and perinatal conditions",2021-09-01,38,0,0,0,"Group B"
"Pregnancy, puerperium and perinatal conditions",2021-09-02,42,0,0,0,"Group B"
"Pregnancy, puerperium and perinatal conditions",2021-09-03,37,0,0,0,"Group B"
"Psychiatric disorders",2021-09-04,21,0,0,0,"Group B"
"Psychiatric disorders",2021-09-05,32,0,0,0,"Group B"
"Psychiatric disorders",2021-09-06,42,0,0,0,"Group B"
"Psychiatric disorders",2021-09-07,36,0,0,0,"Group B"
"Psychiatric disorders",2021-09-08,21,0,0,0,"Group B"
"Psychiatric disorders",2021-09-09,42,0,0,0,"Group B"
"Psychiatric disorders",2021-09-10,21,0,0,0,"Group B"
"Renal and urinary disorders",2021-09-11,37,0,0,0,"Group B"
"Renal and urinary disorders",2021-09-12,24,0,0,0,"Group B"
"Renal and urinary disorders",2021-09-13,31,0,0,0,"Group B"
"Renal and urinary disorders",2021-09-14,29,0,0,0,"Group B"
"Renal and urinary disorders",2021-09-15,39,0,0,0,"Group B"
"Renal and urinary disorders",2021-09-16,26,0,0,0,"Group B"
"Renal and urinary disorders",2021-09-17,27,0,0,0,"Group B"
"Renal and urinary disorders",2021-09-18,38,0,0,0,"Group B"
"Renal and urinary disorders",2021-09-19,35,0,0,0,"Group B"
"Renal and urinary disorders",2021-09-20,34,0,0,0,"Group B"
"Renal and urinary disorders",2021-09-21,21,0,0,0,"Group B"
"Renal and urinary disorders",2021-09-22,24,0,0,0,"Group B"
"Renal and urinary disorders",2021-09-23,26,0,0,0,"Group B"
"Renal and urinary disorders",2021-09-24,39,0,0,0,"Group B"
"Renal and urinary disorders",2021-09-25,26,0,0,0,"Group B"
"Renal and urinary disorders",2021-09-26,21,0,0,0,"Group B"
"Renal and urinary disorders",2021-09-27,35,0,0,0,"Group B"
"Renal and urinary disorders",2021-09-28,26,0,0,0,"Group B"
"Renal and urinary disorders",2021-09-29,21,0,0,0,"Group B"
"Renal and urinary disorders",2021-09-30,24,0,0,0,"Group B"
"Renal and urinary disorders",2021-10-01,21,0,0,0,"Group B"
"Reproductive system and breast disorders",2021-10-02,32,0,0,0,"Group B"
"Reproductive system and breast disorders",2021-10-03,42,0,0,0,"Group B"
"Reproductive system and breast disorders",2021-10-04,36,0,0,0,"Group B"
"Reproductive system and breast disorders",2021-10-05,37,0,0,0,"Group B"
"Reproductive system and breast disorders",2021-10-06,24,0,0,0,"Group B"
"Reproductive system and breast disorders",2021-10-07,31,0,0,0,"Group B"
"Reproductive system and breast disorders",2021-10-08,37,0,0,0,"Group B"
"Reproductive system and breast disorders",2021-10-09,36,0,0,0,"Group B"
"Reproductive system and breast disorders",2021-10-10,32,0,0,0,"Group B"
"Reproductive system and breast disorders",2021-10-11,36,0,0,0,"Group B"
"Reproductive system and breast disorders",2021-10-12,31,0,0,0,"Group B"
"Reproductive system and breast disorders",2021-10-13,31,0,0,0,"Group B"
"Reproductive system and breast disorders",2021-10-14,32,0,0,0,"Group B"
"Reproductive system and breast disorders",2021-10-15,31,0,0,0,"Group B"
"Reproductive system and breast disorders",2021-10-16,31,0,0,0,"Group B"
"Respiratory, thoracic and mediastinal disorders",2021-10-17,29,0,0,0,"Group B"
"Respiratory, thoracic and mediastinal disorders",2021-10-18,39,0,0,0,"Group B"
"Respiratory, thoracic and mediastinal disorders",2021-10-19,26,0,0,0,"Group B"
"Respiratory, thoracic and mediastinal disorders",2021-10-20,29,0,0,0,"Group B"
"Respiratory, thoracic and mediastinal disorders",2021-10-21,29,0,0,0,"Group B"
"Respiratory, thoracic and mediastinal disorders",2021-10-22,26,0,0,0,"Group B"
"Skin and subcutaneous tissue disorders",2021-10-23,27,0,0,0,"Group B"
"Skin and subcutaneous tissue disorders",2021-10-24,38,0,0,0,"Group B"
"Skin and subcutaneous tissue disorders",2021-10-25,35,0,0,0,"Group B"
"Skin and subcutaneous tissue disorders",2021-10-26,34,0,0,0,"Group B"
"Skin and subcutaneous tissue disorders",2021-10-27,21,0,0,0,"Group B"
"Skin and subcutaneous tissue disorders",2021-10-28,34,0,0,0,"Group B"
"Skin and subcutaneous tissue disorders",2021-10-29,21,0,0,0,"Group B"
"Skin and subcutaneous tissue disorders",2021-10-30,35,0,0,0,"Group B"
"Skin and subcutaneous tissue disorders",2021-10-31,34,0,0,0,"Group B"
"Skin and subcutaneous tissue disorders",2021-11-01,34,0,0,0,"Group B"
"Skin and subcutaneous tissue disorders",2021-11-02,35,0,0,0,"Group B"
"Social circumstances",2021-11-03,32,0,0,0,"Group B"
"Social circumstances",2021-11-04,42,0,0,0,"Group B"
"Social circumstances",2021-11-05,36,0,0,0,"Group B"
"Social circumstances",2021-11-06,37,0,0,0,"Group B"
"Social circumstances",2021-11-07,24,0,0,0,"Group B"
"Social circumstances",2021-11-08,31,0,0,0,"Group B"
"Social circumstances",2021-11-09,29,0,0,0,"Group B"
"Surgical and medical procedures",2021-11-10,39,0,0,0,"Group B"
"Surgical and medical procedures",2021-11-11,26,0,0,0,"Group B"
"Surgical and medical procedures",2021-11-12,27,0,0,0,"Group B"
"Surgical and medical procedures",2021-11-13,38,0,0,0,"Group B"
"Surgical and medical procedures",2021-11-14,27,0,0,0,"Group B"
"Surgical and medical procedures",2021-11-15,27,0,0,0,"Group B"
"Surgical and medical procedures",2021-11-16,26,0,0,0,"Group B"
"Surgical and medical procedures",2021-11-17,27,0,0,0,"Group B"
"Surgical and medical procedures",2021-11-18,39,0,0,0,"Group B"
"Surgical and medical procedures",2021-11-19,38,0,0,0,"Group B"
"Vascular disorders",2021-11-20,35,0,0,0,"Group B"
"Vascular disorders",2021-11-21,34,0,0,0,"Group B"
"Vascular disorders",2021-11-22,21,0,0,0,"Group B"
"Vascular disorders",2021-11-23,32,0,0,0,"Group B"
"Vascular disorders",2021-11-24,42,0,0,0,"Group B"
"Blood and lymphatic system disorders",2021-11-25,22,1,0,0,"Group B"
"Blood and lymphatic system disorders",2021-11-26,35,1,1,0,"Group B"
"Blood and lymphatic system disorders",2021-11-27,28,1,1,0,"Group B"
"Blood and lymphatic system disorders",2021-11-28,26,1,0,0,"Group B"
"Blood and lymphatic system disorders",2021-11-29,40,1,0,0,"Group B"
"Blood and lymphatic system disorders",2021-11-30,33,1,1,0,"Group B"
"Blood and lymphatic system disorders",2021-12-01,27,1,0,0,"Group B"
"Blood and lymphatic system disorders",2021-12-02,28,1,0,0,"Group B"
"Blood and lymphatic system disorders",2021-12-03,40,1,0,0,"Group B"
"Blood and lymphatic system disorders",2021-12-04,22,1,0,0,"Group B"
"Blood and lymphatic system disorders",2021-12-05,26,1,1,0,"Group B"
"Blood and lymphatic system disorders",2021-12-06,28,1,0,0,"Group B"
"Blood and lymphatic system disorders",2021-12-07,35,1,1,0,"Group B"
"Blood and lymphatic system disorders",2021-12-08,40,1,1,0,"Group B"
"Blood and lymphatic system disorders",2021-12-09,28,1,1,0,"Group B"
"Blood and lymphatic system disorders",2021-12-10,33,1,0,0,"Group B"
"Cardiac disorders",2021-12-11,24,1,0,0,"Group B"
"Cardiac disorders",2021-12-12,41,1,1,0,"Group B"
"Cardiac disorders",2021-12-13,29,1,1,0,"Group B"
"Cardiac disorders",2021-12-14,42,1,0,0,"Group B"
"Cardiac disorders",2021-12-15,41,1,1,0,"Group B"
"Cardiac disorders",2021-12-16,24,1,1,0,"Group B"
"Cardiac disorders",2021-12-17,41,1,1,0,"Group B"
"Cardiac disorders",2021-12-18,24,1,0,0,"Group B"
"Cardiac disorders",2021-12-19,41,1,0,0,"Group B"
"Congenital, familial and genetic disorders",2021-12-20,30,1,1,0,"Group B"
"Congenital, familial and genetic disorders",2021-12-21,32,1,0,0,"Group B"
"Congenital, familial and genetic disorders",2021-12-22,22,1,1,0,"Group B"
"Congenital, familial and genetic disorders",2021-12-23,35,1,1,0,"Group B"
"Congenital, familial and genetic disorders",2021-12-24,32,1,0,0,"Group B"
"Congenital, familial and genetic disorders",2021-12-25,22,1,1,0,"Group B"
"Congenital, familial and genetic disorders",2021-12-26,22,1,0,0,"Group B"
"Congenital, familial and genetic disorders",2021-12-27,35,1,1,0,"Group B"
"Congenital, familial and genetic disorders",2021-12-28,30,1,1,0,"Group B"
"Congenital, familial and genetic disorders",2021-12-29,35,1,1,0,"Group B"
"Congenital, familial and genetic disorders",2021-12-30,32,1,0,0,"Group B"
"Ear and labyrinth disorders",2021-12-31,28,1,1,0,"Group B"
"Ear and labyrinth disorders",2022-01-01,26,1,0,0,"Group B"
"Ear and labyrinth disorders",2022-01-02,40,1,0,0,"Group B"
"Ear and labyrinth disorders",2022-01-03,33,1,0,0,"Group B"
"Ear and labyrinth disorders",2022-01-04,27,1,1,0,"Group B"
"Ear and labyrinth disorders",2022-01-05,24,1,0,0,"Group B"
"Ear and labyrinth disorders",2022-01-06,33,1,1,0,"Group B"
"Ear and labyrinth disorders",2022-01-07,27,1,0,0,"Group B"
"Ear and labyrinth disorders",2022-01-08,24,1,1,0,"Group B"
"Endocrine disorders",2022-01-09,33,1,0,1,"Group B"
"Endocrine disorders",2022-01-10,29,1,1,0,"Group B"
"Endocrine disorders",2022-01-11,42,1,0,0,"Group B"
"Endocrine disorders",2022-01-12,30,1,1,0,"Group B"
"Endocrine disorders",2022-01-13,32,1,0,0,"Group B"
"Endocrine disorders",2022-01-14,22,1,0,0,"Group B"
"Endocrine disorders",2022-01-15,35,1,1,0,"Group B"
"Endocrine disorders",2022-01-16,28,1,0,0,"Group B"
"Endocrine disorders",2022-01-17,26,1,0,0,"Group B"
"Endocrine disorders",2022-01-18,40,1,1,0,"Group B"
"Endocrine disorders",2022-01-19,27,1,1,0,"Group B"
"Endocrine disorders",2022-01-20,24,1,1,0,"Group B"
"Endocrine disorders",2022-01-21,28,1,1,0,"Group B"
"Endocrine disorders",2022-01-22,42,1,1,0,"Group B"
"Endocrine disorders",2022-01-23,27,1,0,0,"Group B"
"Endocrine disorders",2022-01-24,42,1,1,0,"Group B"
"Endocrine disorders",2022-01-25,33,1,1,0,"Group B"
"Eye disorders",2022-01-26,24,1,1,0,"Group B"
"Eye disorders",2022-01-27,41,1,0,0,"Group B"
"Eye disorders",2022-01-28,29,1,0,0,"Group B"
"Eye disorders",2022-01-29,24,1,0,0,"Group B"
"Eye disorders",2022-01-30,41,1,1,0,"Group B"
"Eye disorders",2022-01-31,29,1,0,0,"Group B"
"Gastrointestinal disorders",2022-02-01,42,1,1,0,"Group B"
"Gastrointestinal disorders",2022-02-02,30,1,1,0,"Group B"
"Gastrointestinal disorders",2022-02-03,32,1,1,0,"Group B"
"Gastrointestinal disorders",2022-02-04,30,1,1,0,"Group B"
"General disorders and administration site conditions",2022-02-05,22,1,1,0,"Group B"
"General disorders and administration site conditions",2022-02-06,35,1,1,0,"Group B"
"General disorders and administration site conditions",2022-02-07,28,1,1,0,"Group B"
"General disorders and administration site conditions",2022-02-08,26,1,1,0,"Group B"
"General disorders and administration site conditions",2022-02-09,40,1,1,0,"Group B"
"General disorders and administration site conditions",2022-02-10,33,1,1,0,"Group B"
"General disorders and administration site conditions",2022-02-11,27,1,1,0,"Group B"
"General disorders and administration site conditions",2022-02-12,40,1,1,0,"Group B"
"General disorders and administration site conditions",2022-02-13,22,1,1,0,"Group B"
"General disorders and administration site conditions",2022-02-14,28,1,1,0,"Group B"
"General disorders and administration site conditions",2022-02-15,35,1,1,0,"Group B"
"General disorders and administration site conditions",2022-02-16,35,1,1,0,"Group B"
"General disorders and administration site conditions",2022-02-17,40,1,1,0,"Group B"
"General disorders and administration site conditions",2022-02-18,27,1,0,0,"Group B"
"General disorders and administration site conditions",2022-02-19,27,1,0,0,"Group B"
"General disorders and administration site conditions",2022-02-20,22,1,1,0,"Group B"
"General disorders and administration site conditions",2022-02-21,26,1,0,0,"Group B"
"Hepatobiliary disorders",2022-02-22,24,1,1,0,"Group B"
"Hepatobiliary disorders",2022-02-23,41,1,0,0,"Group B"
"Hepatobiliary disorders",2022-02-24,29,1,1,0,"Group B"
"Hepatobiliary disorders",2022-02-25,42,1,0,0,"Group B"
"Hepatobiliary disorders",2022-02-26,30,1,0,0,"Group B"
"Hepatobiliary disorders",2022-02-27,32,1,0,0,"Group B"
"Hepatobiliary disorders",2022-02-28,22,1,1,0,"Group B"
"Hepatobiliary disorders",2022-03-01,35,1,0,0,"Group B"
"Hepatobiliary disorders",2022-03-02,28,1,1,0,"Group B"
"Hepatobiliary disorders",2022-03-03,28,1,0,0,"Group B"
"Hepatobiliary disorders",2022-03-04,22,1,1,0,"Group B"
"Hepatobiliary disorders",2022-03-05,32,1,0,0,"Group B"
"Hepatobiliary disorders",2022-03-06,42,1,1,0,"Group B"
"Hepatobiliary disorders",2022-03-07,30,1,1,0,"Group B"
"Hepatobiliary disorders",2022-03-08,41,1,1,0,"Group B"
"Hepatobiliary disorders",2022-03-09,42,1,0,0,"Group B"
"Immune system disorders",2022-03-10,26,1,1,0,"Group B"
"Immune system disorders",2022-03-11,40,1,0,0,"Group B"
"Immune system disorders",2022-03-12,33,1,0,0,"Group B"
"Immune system disorders",2022-03-13,27,1,1,0,"Group B"
"Immune system disorders",2022-03-14,24,1,1,0,"Group B"
"Immune system disorders",2022-03-15,41,1,0,0,"Group B"
"Immune system disorders",2022-03-16,29,1,0,0,"Group B"
"Immune system disorders",2022-03-17,42,1,0,0,"Group B"
"Immune system disorders",2022-03-18,29,1,0,0,"Group B"
"Immune system disorders",2022-03-19,29,1,0,0,"Group B"
"Immune system disorders",2022-03-20,40,1,1,0,"Group B"
"Immune system disorders",2022-03-21,41,1,0,0,"Group B"
"Immune system disorders",2022-03-22,41,1,0,0,"Group B"
"Infections and infestations",2022-03-23,30,1,0,0,"Group B"
"Infections and infestations",2022-03-24,32,1,0,0,"Group B"
"Infections and infestations",2022-03-25,22,1,0,0,"Group B"
"Infections and infestations",2022-03-26,35,1,0,0,"Group B"
"Infections and infestations",2022-03-27,28,1,1,0,"Group B"
"Infections and infestations",2022-03-28,28,1,0,0,"Group B"
"Infections and infestations",2022-03-29,22,1,0,0,"Group B"
"Infections and infestations",2022-03-30,35,1,0,0,"Group B"
"Injury, poisoning and procedural complications",2022-03-31,26,1,1,0,"Group B"
"Injury, poisoning and procedural complications",2022-04-01,40,1,1,0,"Group B"
"Injury, poisoning and procedural complications",2022-04-02,33,1,0,0,"Group B"
"Injury, poisoning and procedural complications",2022-04-03,27,1,1,0,"Group B"
"Injury, poisoning and procedural complications",2022-04-04,24,1,0,0,"Group B"
"Injury, poisoning and procedural complications",2022-04-05,41,1,0,0,"Group B"
"Injury, poisoning and procedural complications",2022-04-06,27,1,1,0,"Group B"
"Injury, poisoning and procedural complications",2022-04-07,24,1,0,0,"Group B"
"Injury, poisoning and procedural complications",2022-04-08,40,1,0,0,"Group B"
"Investigations",2022-04-09,29,1,0,0,"Group B"
"Investigations",2022-04-10,42,1,1,0,"Group B"
"Investigations",2022-04-11,30,1,0,0,"Group B"
"Investigations",2022-04-12,32,1,1,0,"Group B"
"Investigations",2022-04-13,22,1,1,0,"Group B"
"Investigations",2022-04-14,35,1,0,0,"Group B"
"Investigations",2022-04-15,30,1,1,0,"Group B"
"Investigations",2022-04-16,35,1,1,0,"Group B"
"Investigations",2022-04-17,29,1,0,0,"Group B"
"Investigations",2022-04-18,29,1,0,0,"Group B"
"Investigations",2022-04-19,22,1,1,0,"Group B"
"Metabolism and nutrition disorders",2022-04-20,30,1,0,1,"Group B"
"Metabolism and nutrition disorders",2022-04-21,22,1,0,1,"Group B"
"Metabolism and nutrition disorders",2022-04-22,26,1,0,0,"Group B"
"Metabolism and nutrition disorders",2022-04-23,40,1,1,0,"Group B"
"Metabolism and nutrition disorders",2022-04-24,33,1,0,0,"Group B"
"Metabolism and nutrition disorders",2022-04-25,33,1,0,0,"Group B"
"Metabolism and nutrition disorders",2022-04-26,30,1,0,0,"Group B"
"Metabolism and nutrition disorders",2022-04-27,30,1,0,0,"Group B"
"Metabolism and nutrition disorders",2022-04-28,30,1,1,0,"Group B"
"Metabolism and nutrition disorders",2022-04-29,26,1,0,0,"Group B"
"Metabolism and nutrition disorders",2022-04-30,22,1,0,0,"Group B"
"Metabolism and nutrition disorders",2022-05-01,33,1,1,0,"Group B"
"Metabolism and nutrition disorders",2022-05-02,33,1,0,0,"Group B"
"Metabolism and nutrition disorders",2022-05-03,22,1,0,0,"Group B"
"Metabolism and nutrition disorders",2022-05-04,26,1,0,0,"Group B"
"Musculoskeletal and connective tissue disorders",2022-05-05,33,1,0,0,"Group B"
"Musculoskeletal and connective tissue disorders",2022-05-06,27,1,1,0,"Group B"
"Musculoskeletal and connective tissue disorders",2022-05-07,24,1,0,0,"Group B"
"Musculoskeletal and connective tissue disorders",2022-05-08,41,1,0,0,"Group B"
"Musculoskeletal and connective tissue disorders",2022-05-09,41,1,0,0,"Group B"
"Musculoskeletal and connective tissue disorders",2022-05-10,24,1,1,0,"Group B"
"Musculoskeletal and connective tissue disorders",2022-05-11,24,1,0,0,"Group B"
"Musculoskeletal and connective tissue disorders",2022-05-12,27,1,0,0,"Group B"
"Musculoskeletal and connective tissue disorders",2022-05-13,27,1,1,0,"Group B"
"Musculoskeletal and connective tissue disorders",2022-05-14,33,1,0,0,"Group B"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2022-05-15,24,1,1,1,"Group B"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2022-05-16,29,1,1,1,"Group B"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2022-05-17,30,1,1,0,"Group B"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2022-05-18,32,1,1,0,"Group B"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2022-05-19,32,1,1,0,"Group B"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2022-05-20,32,1,1,0,"Group B"
"Nervous system disorders",2022-05-21,30,1,0,0,"Group B"
"Nervous system disorders",2022-05-22,32,1,1,0,"Group B"
"Nervous system disorders",2022-05-23,22,1,0,0,"Group B"
"Nervous system disorders",2022-05-24,35,1,1,0,"Group B"
"Nervous system disorders",2022-05-25,28,1,0,0,"Group B"
"Nervous system disorders",2022-05-26,26,1,1,0,"Group B"
"Nervous system disorders",2022-05-27,28,1,0,0,"Group B"
"Nervous system disorders",2022-05-28,32,1,1,0,"Group B"
"Pregnancy, puerperium and perinatal conditions",2022-05-29,40,1,1,0,"Group B"
"Pregnancy, puerperium and perinatal conditions",2022-05-30,33,1,1,0,"Group B"
"Pregnancy, puerperium and perinatal conditions",2022-05-31,27,1,1,0,"Group B"
"Pregnancy, puerperium and perinatal conditions",2022-06-01,24,1,1,0,"Group B"
"Pregnancy, puerperium and perinatal conditions",2022-06-02,41,1,1,0,"Group B"
"Pregnancy, puerperium and perinatal conditions",2022-06-03,33,1,1,0,"Group B"
"Pregnancy, puerperium and perinatal conditions",2022-06-04,33,1,1,0,"Group B"
"Pregnancy, puerperium and perinatal conditions",2022-06-05,24,1,1,0,"Group B"
"Pregnancy, puerperium and perinatal conditions",2022-06-06,27,1,1,0,"Group B"
"Pregnancy, puerperium and perinatal conditions",2022-06-07,40,1,0,0,"Group B"
"Pregnancy, puerperium and perinatal conditions",2022-06-08,27,1,1,0,"Group B"
"Pregnancy, puerperium and perinatal conditions",2022-06-09,33,1,1,0,"Group B"
"Pregnancy, puerperium and perinatal conditions",2022-06-10,33,1,0,0,"Group B"
"Pregnancy, puerperium and perinatal conditions",2022-06-11,40,1,0,0,"Group B"
"Psychiatric disorders",2022-06-12,29,1,1,0,"Group B"
"Psychiatric disorders",2022-06-13,42,1,0,0,"Group B"
"Psychiatric disorders",2022-06-14,30,1,1,0,"Group B"
"Psychiatric disorders",2022-06-15,32,1,0,0,"Group B"
"Psychiatric disorders",2022-06-16,22,1,0,0,"Group B"
"Psychiatric disorders",2022-06-17,35,1,1,0,"Group B"
"Psychiatric disorders",2022-06-18,28,1,0,0,"Group B"
"Psychiatric disorders",2022-06-19,26,1,0,0,"Group B"
"Psychiatric disorders",2022-06-20,40,1,1,0,"Group B"
"Psychiatric disorders",2022-06-21,33,1,1,0,"Group B"
"Psychiatric disorders",2022-06-22,32,1,1,0,"Group B"
"Psychiatric disorders",2022-06-23,40,1,1,0,"Group B"
"Psychiatric disorders",2022-06-24,35,1,1,0,"Group B"
"Psychiatric disorders",2022-06-25,33,1,0,0,"Group B"
"Psychiatric disorders",2022-06-26,35,1,1,0,"Group B"
"Renal and urinary disorders",2022-06-27,27,1,0,0,"Group B"
"Renal and urinary disorders",2022-06-28,24,1,1,0,"Group B"
"Renal and urinary disorders",2022-06-29,41,1,0,0,"Group B"
"Renal and urinary disorders",2022-06-30,29,1,0,0,"Group B"
"Renal and urinary disorders",2022-07-01,42,1,0,0,"Group B"
"Renal and urinary disorders",2022-07-02,29,1,0,0,"Group B"
"Renal and urinary disorders",2022-07-03,42,1,0,0,"Group B"
"Renal and urinary disorders",2022-07-04,29,1,1,0,"Group B"
"Renal and urinary disorders",2022-07-05,24,1,0,0,"Group B"
"Reproductive system and breast disorders",2022-07-06,30,1,0,0,"Group B"
"Reproductive system and breast disorders",2022-07-07,32,1,1,0,"Group B"
"Reproductive system and breast disorders",2022-07-08,22,1,0,0,"Group B"
"Reproductive system and breast disorders",2022-07-09,22,1,0,0,"Group B"
"Reproductive system and breast disorders",2022-07-10,30,1,1,0,"Group B"
"Respiratory, thoracic and mediastinal disorders",2022-07-11,35,1,0,0,"Group B"
"Respiratory, thoracic and mediastinal disorders",2022-07-12,28,1,0,0,"Group B"
"Respiratory, thoracic and mediastinal disorders",2022-07-13,26,1,1,0,"Group B"
"Respiratory, thoracic and mediastinal disorders",2022-07-14,40,1,0,0,"Group B"
"Respiratory, thoracic and mediastinal disorders",2022-07-15,33,1,1,0,"Group B"
"Respiratory, thoracic and mediastinal disorders",2022-07-16,27,1,0,0,"Group B"
"Respiratory, thoracic and mediastinal disorders",2022-07-17,24,1,1,0,"Group B"
"Respiratory, thoracic and mediastinal disorders",2022-07-18,41,1,1,0,"Group B"
"Respiratory, thoracic and mediastinal disorders",2022-07-19,29,1,1,0,"Group B"
"Respiratory, thoracic and mediastinal disorders",2022-07-20,42,1,1,0,"Group B"
"Respiratory, thoracic and mediastinal disorders",2022-07-21,30,1,1,0,"Group B"
"Respiratory, thoracic and mediastinal disorders",2022-07-22,32,1,1,0,"Group B"
"Respiratory, thoracic and mediastinal disorders",2022-07-23,32,1,1,0,"Group B"
"Respiratory, thoracic and mediastinal disorders",2022-07-24,30,1,0,0,"Group B"
"Respiratory, thoracic and mediastinal disorders",2022-07-25,42,1,0,0,"Group B"
"Respiratory, thoracic and mediastinal disorders",2022-07-26,29,1,1,0,"Group B"
"Respiratory, thoracic and mediastinal disorders",2022-07-27,41,1,0,0,"Group B"
"Respiratory, thoracic and mediastinal disorders",2022-07-28,41,1,0,0,"Group B"
"Respiratory, thoracic and mediastinal disorders",2022-07-29,24,1,0,0,"Group B"
"Respiratory, thoracic and mediastinal disorders",2022-07-30,32,1,1,0,"Group B"
"Respiratory, thoracic and mediastinal disorders",2022-07-31,29,1,0,0,"Group B"
"Respiratory, thoracic and mediastinal disorders",2022-08-01,40,1,1,0,"Group B"
"Skin and subcutaneous tissue disorders",2022-08-02,22,1,1,0,"Group B"
"Skin and subcutaneous tissue disorders",2022-08-03,35,1,1,0,"Group B"
"Skin and subcutaneous tissue disorders",2022-08-04,28,1,1,0,"Group B"
"Skin and subcutaneous tissue disorders",2022-08-05,26,1,0,0,"Group B"
"Skin and subcutaneous tissue disorders",2022-08-06,40,1,1,0,"Group B"
"Skin and subcutaneous tissue disorders",2022-08-07,33,1,0,0,"Group B"
"Skin and subcutaneous tissue disorders",2022-08-08,27,1,0,0,"Group B"
"Skin and subcutaneous tissue disorders",2022-08-09,24,1,0,0,"Group B"
"Skin and subcutaneous tissue disorders",2022-08-10,26,1,1,0,"Group B"
"Skin and subcutaneous tissue disorders",2022-08-11,22,1,1,0,"Group B"
"Social circumstances",2022-08-12,41,1,0,0,"Group B"
"Social circumstances",2022-08-13,29,1,0,0,"Group B"
"Social circumstances",2022-08-14,42,1,0,0,"Group B"
"Social circumstances",2022-08-15,30,1,0,0,"Group B"
"Social circumstances",2022-08-16,32,1,1,0,"Group B"
"Social circumstances",2022-08-17,22,1,1,0,"Group B"
"Social circumstances",2022-08-18,29,1,0,0,"Group B"
"Social circumstances",2022-08-19,41,1,1,0,"Group B"
"Social circumstances",2022-08-20,42,1,0,0,"Group B"
"Social circumstances",2022-08-21,32,1,1,0,"Group B"
"Social circumstances",2022-08-22,42,1,0,0,"Group B"
"Social circumstances",2022-08-23,29,1,1,0,"Group B"
"Surgical and medical procedures",2022-08-24,35,1,1,0,"Group B"
"Surgical and medical procedures",2022-08-25,28,1,1,0,"Group B"
"Surgical and medical procedures",2022-08-26,26,1,0,0,"Group B"
"Surgical and medical procedures",2022-08-27,40,1,0,0,"Group B"
"Surgical and medical procedures",2022-08-28,33,1,0,0,"Group B"
"Surgical and medical procedures",2022-08-29,27,1,1,0,"Group B"
"Surgical and medical procedures",2022-08-30,24,1,1,0,"Group B"
"Surgical and medical procedures",2022-08-31,41,1,1,0,"Group B"
"Surgical and medical procedures",2022-09-01,29,1,1,0,"Group B"
"Surgical and medical procedures",2022-09-02,29,1,0,0,"Group B"
"Surgical and medical procedures",2022-09-03,27,1,0,0,"Group B"
"Surgical and medical procedures",2022-09-04,26,1,1,0,"Group B"
"Surgical and medical procedures",2022-09-05,41,1,0,0,"Group B"
"Surgical and medical procedures",2022-09-06,33,1,1,0,"Group B"
"Surgical and medical procedures",2022-09-07,27,1,0,0,"Group B"
"Surgical and medical procedures",2022-09-08,29,1,1,0,"Group B"
"Vascular disorders",2022-09-09,40,1,1,1,"Group B"
"Vascular disorders",2022-09-10,30,1,0,0,"Group B"
"Vascular disorders",2022-09-11,32,1,0,0,"Group B"
"Vascular disorders",2022-09-12,22,1,0,0,"Group B"
"Vascular disorders",2022-09-13,35,1,0,0,"Group B"
"Vascular disorders",2022-09-14,28,1,0,0,"Group B"
"Vascular disorders",2022-09-15,35,1,0,0,"Group B"
"Vascular disorders",2022-09-16,32,1,0,0,"Group B"
"Vascular disorders",2022-09-17,35,1,0,0,"Group B"
"Vascular disorders",2022-09-18,32,1,0,0,"Group B"
"Vascular disorders",2022-09-19,28,1,0,0,"Group B"
"Blood and lymphatic system disorders",2022-09-20,47,0,0,0,"Group C"
"Blood and lymphatic system disorders",2022-09-21,45,0,0,0,"Group C"
"Blood and lymphatic system disorders",2022-09-22,60,0,0,0,"Group C"
"Blood and lymphatic system disorders",2022-09-23,54,0,0,0,"Group C"
"Blood and lymphatic system disorders",2022-09-24,55,0,0,0,"Group C"
"Blood and lymphatic system disorders",2022-09-25,55,0,0,0,"Group C"
"Blood and lymphatic system disorders",2022-09-26,47,0,0,0,"Group C"
"Blood and lymphatic system disorders",2022-09-27,54,0,0,0,"Group C"
"Blood and lymphatic system disorders",2022-09-28,60,0,0,0,"Group C"
"Blood and lymphatic system disorders",2022-09-29,47,0,0,0,"Group C"
"Blood and lymphatic system disorders",2022-09-30,60,0,0,0,"Group C"
"Cardiac disorders",2022-10-01,49,0,0,0,"Group C"
"Cardiac disorders",2022-10-02,53,0,0,0,"Group C"
"Cardiac disorders",2022-10-03,56,0,0,0,"Group C"
"Cardiac disorders",2022-10-04,56,0,0,0,"Group C"
"Cardiac disorders",2022-10-05,49,0,0,0,"Group C"
"Cardiac disorders",2022-10-06,56,0,0,0,"Group C"
"Congenital, familial and genetic disorders",2022-10-07,44,0,0,0,"Group C"
"Congenital, familial and genetic disorders",2022-10-08,46,0,0,0,"Group C"
"Congenital, familial and genetic disorders",2022-10-09,43,0,0,0,"Group C"
"Congenital, familial and genetic disorders",2022-10-10,47,0,0,0,"Group C"
"Congenital, familial and genetic disorders",2022-10-11,45,0,0,0,"Group C"
"Congenital, familial and genetic disorders",2022-10-12,60,0,0,0,"Group C"
"Congenital, familial and genetic disorders",2022-10-13,54,0,0,0,"Group C"
"Ear and labyrinth disorders",2022-10-14,55,0,0,0,"Group C"
"Ear and labyrinth disorders",2022-10-15,49,0,0,0,"Group C"
"Ear and labyrinth disorders",2022-10-16,53,0,0,0,"Group C"
"Ear and labyrinth disorders",2022-10-17,56,0,0,0,"Group C"
"Ear and labyrinth disorders",2022-10-18,44,0,0,0,"Group C"
"Ear and labyrinth disorders",2022-10-19,55,0,0,0,"Group C"
"Ear and labyrinth disorders",2022-10-20,53,0,0,0,"Group C"
"Ear and labyrinth disorders",2022-10-21,49,0,0,0,"Group C"
"Endocrine disorders",2022-10-22,46,0,0,0,"Group C"
"Endocrine disorders",2022-10-23,43,0,0,0,"Group C"
"Endocrine disorders",2022-10-24,47,0,0,0,"Group C"
"Endocrine disorders",2022-10-25,45,0,0,0,"Group C"
"Eye disorders",2022-10-26,60,0,0,0,"Group C"
"Eye disorders",2022-10-27,54,0,0,0,"Group C"
"Eye disorders",2022-10-28,55,0,0,0,"Group C"
"Eye disorders",2022-10-29,49,0,0,0,"Group C"
"Eye disorders",2022-10-30,53,0,0,0,"Group C"
"Eye disorders",2022-10-31,56,0,0,0,"Group C"
"Eye disorders",2022-11-01,44,0,0,0,"Group C"
"Eye disorders",2022-11-02,46,0,0,0,"Group C"
"Eye disorders",2022-11-03,46,0,0,0,"Group C"
"Eye disorders",2022-11-04,46,0,0,0,"Group C"
"Eye disorders",2022-11-05,49,0,0,0,"Group C"
"Eye disorders",2022-11-06,56,0,0,0,"Group C"
"Eye disorders",2022-11-07,55,0,0,0,"Group C"
"Eye disorders",2022-11-08,56,0,0,0,"Group C"
"Eye disorders",2022-11-09,60,0,0,0,"Group C"
"Eye disorders",2022-11-10,49,0,0,0,"Group C"
"Gastrointestinal disorders",2022-11-11,43,0,0,0,"Group C"
"Gastrointestinal disorders",2022-11-12,47,0,0,0,"Group C"
"Gastrointestinal disorders",2022-11-13,45,0,0,0,"Group C"
"Gastrointestinal disorders",2022-11-14,60,0,0,0,"Group C"
"Gastrointestinal disorders",2022-11-15,54,0,0,0,"Group C"
"Gastrointestinal disorders",2022-11-16,55,0,0,0,"Group C"
"Gastrointestinal disorders",2022-11-17,49,0,0,0,"Group C"
"Gastrointestinal disorders",2022-11-18,49,0,0,0,"Group C"
"Gastrointestinal disorders",2022-11-19,54,0,0,0,"Group C"
"Gastrointestinal disorders",2022-11-20,45,0,0,0,"Group C"
"Gastrointestinal disorders",2022-11-21,55,0,0,0,"Group C"
"Gastrointestinal disorders",2022-11-22,43,0,0,0,"Group C"
"Gastrointestinal disorders",2022-11-23,54,0,0,0,"Group C"
"General disorders and administration site conditions",2022-11-24,53,0,0,0,"Group C"
"General disorders and administration site conditions",2022-11-25,56,0,0,0,"Group C"
"General disorders and administration site conditions",2022-11-26,44,0,0,0,"Group C"
"General disorders and administration site conditions",2022-11-27,46,0,0,0,"Group C"
"General disorders and administration site conditions",2022-11-28,43,0,0,0,"Group C"
"General disorders and administration site conditions",2022-11-29,47,0,0,0,"Group C"
"General disorders and administration site conditions",2022-11-30,45,0,0,0,"Group C"
"General disorders and administration site conditions",2022-12-01,60,0,0,0,"Group C"
"General disorders and administration site conditions",2022-12-02,54,0,0,0,"Group C"
"General disorders and administration site conditions",2022-12-03,55,0,0,0,"Group C"
"General disorders and administration site conditions",2022-12-04,44,0,0,0,"Group C"
"General disorders and administration site conditions",2022-12-05,54,0,0,0,"Group C"
"General disorders and administration site conditions",2022-12-06,47,0,0,0,"Group C"
"General disorders and administration site conditions",2022-12-07,44,0,0,0,"Group C"
"General disorders and administration site conditions",2022-12-08,44,0,0,0,"Group C"
"Hepatobiliary disorders",2022-12-09,49,0,0,0,"Group C"
"Hepatobiliary disorders",2022-12-10,53,0,0,0,"Group C"
"Hepatobiliary disorders",2022-12-11,56,0,0,0,"Group C"
"Hepatobiliary disorders",2022-12-12,53,0,0,0,"Group C"
"Hepatobiliary disorders",2022-12-13,53,0,0,0,"Group C"
"Hepatobiliary disorders",2022-12-14,53,0,0,0,"Group C"
"Hepatobiliary disorders",2022-12-15,53,0,0,0,"Group C"
"Hepatobiliary disorders",2022-12-16,49,0,0,0,"Group C"
"Hepatobiliary disorders",2022-12-17,49,0,0,0,"Group C"
"Immune system disorders",2022-12-18,44,0,0,0,"Group C"
"Immune system disorders",2022-12-19,46,0,0,0,"Group C"
"Immune system disorders",2022-12-20,43,0,0,0,"Group C"
"Immune system disorders",2022-12-21,44,0,0,0,"Group C"
"Immune system disorders",2022-12-22,44,0,0,0,"Group C"
"Immune system disorders",2022-12-23,44,0,0,0,"Group C"
"Immune system disorders",2022-12-24,46,0,0,0,"Group C"
"Immune system disorders",2022-12-25,46,0,0,0,"Group C"
"Infections and infestations",2022-12-26,47,0,0,0,"Group C"
"Infections and infestations",2022-12-27,45,0,0,0,"Group C"
"Infections and infestations",2022-12-28,60,0,0,0,"Group C"
"Infections and infestations",2022-12-29,60,0,0,0,"Group C"
"Injury, poisoning and procedural complications",2022-12-30,54,0,0,0,"Group C"
"Injury, poisoning and procedural complications",2022-12-31,55,0,0,0,"Group C"
"Injury, poisoning and procedural complications",2023-01-01,49,0,0,0,"Group C"
"Injury, poisoning and procedural complications",2023-01-02,53,0,0,0,"Group C"
"Injury, poisoning and procedural complications",2023-01-03,56,0,0,0,"Group C"
"Injury, poisoning and procedural complications",2023-01-04,44,0,0,0,"Group C"
"Injury, poisoning and procedural complications",2023-01-05,46,0,0,0,"Group C"
"Injury, poisoning and procedural complications",2023-01-06,43,0,0,0,"Group C"
"Injury, poisoning and procedural complications",2023-01-07,56,0,0,0,"Group C"
"Injury, poisoning and procedural complications",2023-01-08,46,0,0,0,"Group C"
"Injury, poisoning and procedural complications",2023-01-09,46,0,0,0,"Group C"
"Injury, poisoning and procedural complications",2023-01-10,56,0,0,0,"Group C"
"Injury, poisoning and procedural complications",2023-01-11,44,0,0,0,"Group C"
"Injury, poisoning and procedural complications",2023-01-12,53,0,0,0,"Group C"
"Injury, poisoning and procedural complications",2023-01-13,53,0,0,0,"Group C"
"Injury, poisoning and procedural complications",2023-01-14,49,0,0,0,"Group C"
"Injury, poisoning and procedural complications",2023-01-15,53,0,0,0,"Group C"
"Investigations",2023-01-16,47,0,0,0,"Group C"
"Investigations",2023-01-17,45,0,0,0,"Group C"
"Investigations",2023-01-18,45,0,0,0,"Group C"
"Investigations",2023-01-19,45,0,0,0,"Group C"
"Investigations",2023-01-20,45,0,0,0,"Group C"
"Investigations",2023-01-21,47,0,0,0,"Group C"
"Investigations",2023-01-22,47,0,0,0,"Group C"
"Metabolism and nutrition disorders",2023-01-23,60,0,0,0,"Group C"
"Metabolism and nutrition disorders",2023-01-24,54,0,0,0,"Group C"
"Metabolism and nutrition disorders",2023-01-25,55,0,0,0,"Group C"
"Metabolism and nutrition disorders",2023-01-26,49,0,0,0,"Group C"
"Metabolism and nutrition disorders",2023-01-27,53,0,0,0,"Group C"
"Metabolism and nutrition disorders",2023-01-28,56,0,0,0,"Group C"
"Metabolism and nutrition disorders",2023-01-29,44,0,0,0,"Group C"
"Metabolism and nutrition disorders",2023-01-30,46,0,0,0,"Group C"
"Metabolism and nutrition disorders",2023-01-31,43,0,0,0,"Group C"
"Metabolism and nutrition disorders",2023-02-01,47,0,0,0,"Group C"
"Metabolism and nutrition disorders",2023-02-02,45,0,0,0,"Group C"
"Metabolism and nutrition disorders",2023-02-03,56,0,0,0,"Group C"
"Metabolism and nutrition disorders",2023-02-04,46,0,0,0,"Group C"
"Metabolism and nutrition disorders",2023-02-05,45,0,0,0,"Group C"
"Metabolism and nutrition disorders",2023-02-06,47,0,0,0,"Group C"
"Metabolism and nutrition disorders",2023-02-07,55,0,0,0,"Group C"
"Metabolism and nutrition disorders",2023-02-08,49,0,0,0,"Group C"
"Metabolism and nutrition disorders",2023-02-09,53,0,0,0,"Group C"
"Musculoskeletal and connective tissue disorders",2023-02-10,60,0,0,0,"Group C"
"Musculoskeletal and connective tissue disorders",2023-02-11,54,0,0,0,"Group C"
"Musculoskeletal and connective tissue disorders",2023-02-12,55,0,0,0,"Group C"
"Musculoskeletal and connective tissue disorders",2023-02-13,49,0,0,0,"Group C"
"Musculoskeletal and connective tissue disorders",2023-02-14,53,0,0,0,"Group C"
"Musculoskeletal and connective tissue disorders",2023-02-15,56,0,0,0,"Group C"
"Musculoskeletal and connective tissue disorders",2023-02-16,44,0,0,0,"Group C"
"Musculoskeletal and connective tissue disorders",2023-02-17,46,0,0,0,"Group C"
"Musculoskeletal and connective tissue disorders",2023-02-18,43,0,0,0,"Group C"
"Musculoskeletal and connective tissue disorders",2023-02-19,44,0,0,0,"Group C"
"Musculoskeletal and connective tissue disorders",2023-02-20,55,0,0,0,"Group C"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2023-02-21,47,0,0,0,"Group C"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2023-02-22,45,0,0,0,"Group C"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2023-02-23,60,0,0,0,"Group C"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2023-02-24,54,0,0,0,"Group C"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2023-02-25,55,0,0,0,"Group C"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2023-02-26,60,0,0,0,"Group C"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2023-02-27,45,0,0,0,"Group C"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2023-02-28,60,0,0,0,"Group C"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2023-03-01,54,0,0,0,"Group C"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2023-03-02,54,0,0,0,"Group C"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2023-03-03,45,0,0,0,"Group C"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2023-03-04,60,0,0,0,"Group C"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2023-03-05,54,0,0,0,"Group C"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2023-03-06,60,0,0,0,"Group C"
"Nervous system disorders",2023-03-07,49,0,0,0,"Group C"
"Nervous system disorders",2023-03-08,53,0,0,0,"Group C"
"Nervous system disorders",2023-03-09,56,0,0,0,"Group C"
"Nervous system disorders",2023-03-10,44,0,0,0,"Group C"
"Nervous system disorders",2023-03-11,46,0,0,0,"Group C"
"Nervous system disorders",2023-03-12,43,0,0,0,"Group C"
"Nervous system disorders",2023-03-13,47,0,0,0,"Group C"
"Nervous system disorders",2023-03-14,45,0,0,0,"Group C"
"Nervous system disorders",2023-03-15,44,0,0,0,"Group C"
"Nervous system disorders",2023-03-16,47,0,0,0,"Group C"
"Nervous system disorders",2023-03-17,46,0,0,0,"Group C"
"Nervous system disorders",2023-03-18,43,0,0,0,"Group C"
"Nervous system disorders",2023-03-19,43,0,0,0,"Group C"
"Nervous system disorders",2023-03-20,46,0,0,0,"Group C"
"Nervous system disorders",2023-03-21,43,0,0,0,"Group C"
"Nervous system disorders",2023-03-22,47,0,0,0,"Group C"
"Nervous system disorders",2023-03-23,56,0,0,0,"Group C"
"Nervous system disorders",2023-03-24,49,0,0,0,"Group C"
"Pregnancy, puerperium and perinatal conditions",2023-03-25,60,0,0,0,"Group C"
"Pregnancy, puerperium and perinatal conditions",2023-03-26,54,0,0,0,"Group C"
"Pregnancy, puerperium and perinatal conditions",2023-03-27,55,0,0,0,"Group C"
"Pregnancy, puerperium and perinatal conditions",2023-03-28,49,0,0,0,"Group C"
"Pregnancy, puerperium and perinatal conditions",2023-03-29,53,0,0,0,"Group C"
"Pregnancy, puerperium and perinatal conditions",2023-03-30,56,0,0,0,"Group C"
"Pregnancy, puerperium and perinatal conditions",2023-03-31,55,0,0,0,"Group C"
"Psychiatric disorders",2023-04-01,44,0,0,0,"Group C"
"Psychiatric disorders",2023-04-02,46,0,0,0,"Group C"
"Psychiatric disorders",2023-04-03,43,0,0,0,"Group C"
"Psychiatric disorders",2023-04-04,47,0,0,0,"Group C"
"Psychiatric disorders",2023-04-05,45,0,0,0,"Group C"
"Psychiatric disorders",2023-04-06,60,0,0,0,"Group C"
"Psychiatric disorders",2023-04-07,54,0,0,0,"Group C"
"Psychiatric disorders",2023-04-08,44,0,0,0,"Group C"
"Renal and urinary disorders",2023-04-09,55,0,0,0,"Group C"
"Renal and urinary disorders",2023-04-10,49,0,0,0,"Group C"
"Renal and urinary disorders",2023-04-11,53,0,0,0,"Group C"
"Renal and urinary disorders",2023-04-12,56,0,0,0,"Group C"
"Renal and urinary disorders",2023-04-13,44,0,0,0,"Group C"
"Renal and urinary disorders",2023-04-14,49,0,0,0,"Group C"
"Renal and urinary disorders",2023-04-15,49,0,0,0,"Group C"
"Renal and urinary disorders",2023-04-16,56,0,0,0,"Group C"
"Renal and urinary disorders",2023-04-17,53,0,0,0,"Group C"
"Renal and urinary disorders",2023-04-18,44,0,0,0,"Group C"
"Renal and urinary disorders",2023-04-19,53,0,0,0,"Group C"
"Reproductive system and breast disorders",2023-04-20,46,0,0,0,"Group C"
"Reproductive system and breast disorders",2023-04-21,43,0,0,0,"Group C"
"Reproductive system and breast disorders",2023-04-22,47,0,0,0,"Group C"
"Reproductive system and breast disorders",2023-04-23,45,0,0,0,"Group C"
"Reproductive system and breast disorders",2023-04-24,60,0,0,0,"Group C"
"Reproductive system and breast disorders",2023-04-25,54,0,0,0,"Group C"
"Reproductive system and breast disorders",2023-04-26,54,0,0,0,"Group C"
"Reproductive system and breast disorders",2023-04-27,54,0,0,0,"Group C"
"Reproductive system and breast disorders",2023-04-28,47,0,0,0,"Group C"
"Reproductive system and breast disorders",2023-04-29,46,0,0,0,"Group C"
"Reproductive system and breast disorders",2023-04-30,45,0,0,0,"Group C"
"Respiratory, thoracic and mediastinal disorders",2023-05-01,55,0,0,0,"Group C"
"Respiratory, thoracic and mediastinal disorders",2023-05-02,49,0,0,0,"Group C"
"Respiratory, thoracic and mediastinal disorders",2023-05-03,53,0,0,0,"Group C"
"Respiratory, thoracic and mediastinal disorders",2023-05-04,56,0,0,0,"Group C"
"Respiratory, thoracic and mediastinal disorders",2023-05-05,44,0,0,0,"Group C"
"Respiratory, thoracic and mediastinal disorders",2023-05-06,46,0,0,0,"Group C"
"Respiratory, thoracic and mediastinal disorders",2023-05-07,43,0,0,0,"Group C"
"Respiratory, thoracic and mediastinal disorders",2023-05-08,47,0,0,0,"Group C"
"Respiratory, thoracic and mediastinal disorders",2023-05-09,53,0,0,0,"Group C"
"Respiratory, thoracic and mediastinal disorders",2023-05-10,49,0,0,0,"Group C"
"Respiratory, thoracic and mediastinal disorders",2023-05-11,55,0,0,0,"Group C"
"Respiratory, thoracic and mediastinal disorders",2023-05-12,47,0,0,0,"Group C"
"Respiratory, thoracic and mediastinal disorders",2023-05-13,47,0,0,0,"Group C"
"Respiratory, thoracic and mediastinal disorders",2023-05-14,43,0,0,0,"Group C"
"Skin and subcutaneous tissue disorders",2023-05-15,45,0,0,0,"Group C"
"Skin and subcutaneous tissue disorders",2023-05-16,60,0,0,0,"Group C"
"Skin and subcutaneous tissue disorders",2023-05-17,54,0,0,0,"Group C"
"Skin and subcutaneous tissue disorders",2023-05-18,55,0,0,0,"Group C"
"Skin and subcutaneous tissue disorders",2023-05-19,49,0,0,0,"Group C"
"Skin and subcutaneous tissue disorders",2023-05-20,49,0,0,0,"Group C"
"Skin and subcutaneous tissue disorders",2023-05-21,45,0,0,0,"Group C"
"Skin and subcutaneous tissue disorders",2023-05-22,49,0,0,0,"Group C"
"Skin and subcutaneous tissue disorders",2023-05-23,54,0,0,0,"Group C"
"Skin and subcutaneous tissue disorders",2023-05-24,55,0,0,0,"Group C"
"Skin and subcutaneous tissue disorders",2023-05-25,60,0,0,0,"Group C"
"Skin and subcutaneous tissue disorders",2023-05-26,54,0,0,0,"Group C"
"Skin and subcutaneous tissue disorders",2023-05-27,60,0,0,0,"Group C"
"Skin and subcutaneous tissue disorders",2023-05-28,55,0,0,0,"Group C"
"Skin and subcutaneous tissue disorders",2023-05-29,49,0,0,0,"Group C"
"Social circumstances",2023-05-30,53,0,0,0,"Group C"
"Social circumstances",2023-05-31,53,0,0,0,"Group C"
"Social circumstances",2023-06-01,53,0,0,0,"Group C"
"Surgical and medical procedures",2023-06-02,56,0,0,0,"Group C"
"Surgical and medical procedures",2023-06-03,44,0,0,0,"Group C"
"Surgical and medical procedures",2023-06-04,46,0,0,0,"Group C"
"Surgical and medical procedures",2023-06-05,43,0,0,0,"Group C"
"Surgical and medical procedures",2023-06-06,44,0,0,0,"Group C"
"Surgical and medical procedures",2023-06-07,44,0,0,0,"Group C"
"Surgical and medical procedures",2023-06-08,43,0,0,0,"Group C"
"Surgical and medical procedures",2023-06-09,56,0,0,0,"Group C"
"Surgical and medical procedures",2023-06-10,56,0,0,0,"Group C"
"Surgical and medical procedures",2023-06-11,46,0,0,0,"Group C"
"Surgical and medical procedures",2023-06-12,44,0,0,0,"Group C"
"Surgical and medical procedures",2023-06-13,46,0,0,0,"Group C"
"Surgical and medical procedures",2023-06-14,44,0,0,0,"Group C"
"Surgical and medical procedures",2023-06-15,56,0,0,0,"Group C"
"Vascular disorders",2023-06-16,47,0,0,0,"Group C"
"Vascular disorders",2023-06-17,45,0,0,0,"Group C"
"Vascular disorders",2023-06-18,60,0,0,0,"Group C"
"Vascular disorders",2023-06-19,54,0,0,0,"Group C"
"Vascular disorders",2023-06-20,55,0,0,0,"Group C"
"Vascular disorders",2023-06-21,49,0,0,0,"Group C"
"Vascular disorders",2023-06-22,53,0,0,0,"Group C"
"Vascular disorders",2023-06-23,49,0,0,0,"Group C"
"Blood and lymphatic system disorders",2023-06-24,53,1,0,0,"Group C"
"Blood and lymphatic system disorders",2023-06-25,56,1,0,0,"Group C"
"Blood and lymphatic system disorders",2023-06-26,52,1,0,0,"Group C"
"Blood and lymphatic system disorders",2023-06-27,52,1,0,0,"Group C"
"Blood and lymphatic system disorders",2023-06-28,52,1,1,0,"Group C"
"Blood and lymphatic system disorders",2023-06-29,53,1,0,0,"Group C"
"Blood and lymphatic system disorders",2023-06-30,53,1,0,0,"Group C"
"Blood and lymphatic system disorders",2023-07-01,52,1,0,0,"Group C"
"Blood and lymphatic system disorders",2023-07-02,56,1,0,0,"Group C"
"Blood and lymphatic system disorders",2023-07-03,53,1,0,0,"Group C"
"Blood and lymphatic system disorders",2023-07-04,53,1,0,0,"Group C"
"Blood and lymphatic system disorders",2023-07-05,53,1,0,0,"Group C"
"Blood and lymphatic system disorders",2023-07-06,56,1,0,0,"Group C"
"Cardiac disorders",2023-07-07,55,1,0,0,"Group C"
"Cardiac disorders",2023-07-08,54,1,1,0,"Group C"
"Cardiac disorders",2023-07-09,50,1,1,0,"Group C"
"Cardiac disorders",2023-07-10,44,1,1,0,"Group C"
"Cardiac disorders",2023-07-11,46,1,0,0,"Group C"
"Cardiac disorders",2023-07-12,49,1,1,0,"Group C"
"Cardiac disorders",2023-07-13,53,1,0,0,"Group C"
"Cardiac disorders",2023-07-14,56,1,1,0,"Group C"
"Cardiac disorders",2023-07-15,52,1,1,0,"Group C"
"Cardiac disorders",2023-07-16,56,1,1,0,"Group C"
"Cardiac disorders",2023-07-17,46,1,1,0,"Group C"
"Cardiac disorders",2023-07-18,50,1,1,0,"Group C"
"Cardiac disorders",2023-07-19,49,1,1,0,"Group C"
"Cardiac disorders",2023-07-20,54,1,0,0,"Group C"
"Cardiac disorders",2023-07-21,54,1,0,0,"Group C"
"Congenital, familial and genetic disorders",2023-07-22,53,1,0,1,"Group C"
"Congenital, familial and genetic disorders",2023-07-23,54,1,1,0,"Group C"
"Congenital, familial and genetic disorders",2023-07-24,50,1,1,0,"Group C"
"Congenital, familial and genetic disorders",2023-07-25,44,1,0,0,"Group C"
"Congenital, familial and genetic disorders",2023-07-26,46,1,1,0,"Group C"
"Congenital, familial and genetic disorders",2023-07-27,49,1,1,0,"Group C"
"Congenital, familial and genetic disorders",2023-07-28,56,1,1,0,"Group C"
"Congenital, familial and genetic disorders",2023-07-29,52,1,1,0,"Group C"
"Congenital, familial and genetic disorders",2023-07-30,55,1,1,0,"Group C"
"Congenital, familial and genetic disorders",2023-07-31,46,1,1,0,"Group C"
"Congenital, familial and genetic disorders",2023-08-01,55,1,0,0,"Group C"
"Congenital, familial and genetic disorders",2023-08-02,44,1,0,0,"Group C"
"Congenital, familial and genetic disorders",2023-08-03,55,1,1,0,"Group C"
"Congenital, familial and genetic disorders",2023-08-04,53,1,0,0,"Group C"
"Ear and labyrinth disorders",2023-08-05,55,1,1,0,"Group C"
"Ear and labyrinth disorders",2023-08-06,54,1,0,0,"Group C"
"Ear and labyrinth disorders",2023-08-07,50,1,1,0,"Group C"
"Ear and labyrinth disorders",2023-08-08,44,1,0,0,"Group C"
"Ear and labyrinth disorders",2023-08-09,44,1,1,0,"Group C"
"Ear and labyrinth disorders",2023-08-10,54,1,0,0,"Group C"
"Ear and labyrinth disorders",2023-08-11,54,1,1,0,"Group C"
"Ear and labyrinth disorders",2023-08-12,55,1,1,0,"Group C"
"Ear and labyrinth disorders",2023-08-13,55,1,1,0,"Group C"
"Ear and labyrinth disorders",2023-08-14,55,1,0,0,"Group C"
"Endocrine disorders",2023-08-15,46,1,0,0,"Group C"
"Endocrine disorders",2023-08-16,49,1,0,0,"Group C"
"Endocrine disorders",2023-08-17,53,1,1,0,"Group C"
"Endocrine disorders",2023-08-18,46,1,0,0,"Group C"
"Endocrine disorders",2023-08-19,46,1,0,0,"Group C"
"Endocrine disorders",2023-08-20,53,1,0,0,"Group C"
"Endocrine disorders",2023-08-21,53,1,0,0,"Group C"
"Endocrine disorders",2023-08-22,53,1,1,0,"Group C"
"Eye disorders",2023-08-23,56,1,0,0,"Group C"
"Eye disorders",2023-08-24,52,1,0,0,"Group C"
"Eye disorders",2023-08-25,55,1,0,0,"Group C"
"Eye disorders",2023-08-26,54,1,1,0,"Group C"
"Eye disorders",2023-08-27,55,1,0,0,"Group C"
"Eye disorders",2023-08-28,52,1,0,0,"Group C"
"Eye disorders",2023-08-29,54,1,0,0,"Group C"
"Gastrointestinal disorders",2023-08-30,50,1,0,0,"Group C"
"Gastrointestinal disorders",2023-08-31,44,1,0,0,"Group C"
"Gastrointestinal disorders",2023-09-01,50,1,0,0,"Group C"
"Gastrointestinal disorders",2023-09-02,50,1,0,0,"Group C"
"Gastrointestinal disorders",2023-09-03,44,1,1,0,"Group C"
"Gastrointestinal disorders",2023-09-04,50,1,0,0,"Group C"
"Gastrointestinal disorders",2023-09-05,44,1,1,0,"Group C"
"Gastrointestinal disorders",2023-09-06,50,1,1,0,"Group C"
"General disorders and administration site conditions",2023-09-07,46,1,0,0,"Group C"
"General disorders and administration site conditions",2023-09-08,49,1,1,0,"Group C"
"General disorders and administration site conditions",2023-09-09,53,1,0,0,"Group C"
"General disorders and administration site conditions",2023-09-10,56,1,0,0,"Group C"
"General disorders and administration site conditions",2023-09-11,52,1,0,0,"Group C"
"General disorders and administration site conditions",2023-09-12,55,1,0,0,"Group C"
"General disorders and administration site conditions",2023-09-13,55,1,1,0,"Group C"
"General disorders and administration site conditions",2023-09-14,46,1,0,0,"Group C"
"General disorders and administration site conditions",2023-09-15,55,1,0,0,"Group C"
"General disorders and administration site conditions",2023-09-16,49,1,0,0,"Group C"
"General disorders and administration site conditions",2023-09-17,53,1,1,0,"Group C"
"General disorders and administration site conditions",2023-09-18,56,1,0,0,"Group C"
"General disorders and administration site conditions",2023-09-19,46,1,0,0,"Group C"
"General disorders and administration site conditions",2023-09-20,49,1,0,0,"Group C"
"Hepatobiliary disorders",2023-09-21,54,1,0,0,"Group C"
"Hepatobiliary disorders",2023-09-22,54,1,0,0,"Group C"
"Hepatobiliary disorders",2023-09-23,54,1,0,0,"Group C"
"Hepatobiliary disorders",2023-09-24,54,1,0,0,"Group C"
"Hepatobiliary disorders",2023-09-25,54,1,0,0,"Group C"
"Hepatobiliary disorders",2023-09-26,54,1,0,0,"Group C"
"Immune system disorders",2023-09-27,50,1,1,0,"Group C"
"Immune system disorders",2023-09-28,44,1,0,0,"Group C"
"Immune system disorders",2023-09-29,46,1,0,0,"Group C"
"Immune system disorders",2023-09-30,49,1,1,0,"Group C"
"Immune system disorders",2023-10-01,53,1,0,0,"Group C"
"Immune system disorders",2023-10-02,56,1,0,0,"Group C"
"Immune system disorders",2023-10-03,52,1,1,0,"Group C"
"Immune system disorders",2023-10-04,46,1,0,0,"Group C"
"Immune system disorders",2023-10-05,50,1,1,0,"Group C"
"Immune system disorders",2023-10-06,44,1,1,0,"Group C"
"Immune system disorders",2023-10-07,53,1,0,0,"Group C"
"Infections and infestations",2023-10-08,55,1,0,0,"Group C"
"Infections and infestations",2023-10-09,54,1,1,0,"Group C"
"Infections and infestations",2023-10-10,50,1,0,0,"Group C"
"Infections and infestations",2023-10-11,44,1,1,0,"Group C"
"Infections and infestations",2023-10-12,55,1,1,0,"Group C"
"Infections and infestations",2023-10-13,44,1,0,0,"Group C"
"Infections and infestations",2023-10-14,50,1,0,0,"Group C"
"Infections and infestations",2023-10-15,44,1,0,0,"Group C"
"Infections and infestations",2023-10-16,54,1,1,0,"Group C"
"Infections and infestations",2023-10-17,44,1,0,0,"Group C"
"Injury, poisoning and procedural complications",2023-10-18,46,1,1,0,"Group C"
"Injury, poisoning and procedural complications",2023-10-19,49,1,0,0,"Group C"
"Injury, poisoning and procedural complications",2023-10-20,53,1,1,0,"Group C"
"Injury, poisoning and procedural complications",2023-10-21,56,1,1,0,"Group C"
"Injury, poisoning and procedural complications",2023-10-22,52,1,1,0,"Group C"
"Injury, poisoning and procedural complications",2023-10-23,55,1,1,0,"Group C"
"Injury, poisoning and procedural complications",2023-10-24,54,1,1,0,"Group C"
"Injury, poisoning and procedural complications",2023-10-25,56,1,1,0,"Group C"
"Injury, poisoning and procedural complications",2023-10-26,56,1,1,0,"Group C"
"Injury, poisoning and procedural complications",2023-10-27,55,1,0,0,"Group C"
"Injury, poisoning and procedural complications",2023-10-28,53,1,0,0,"Group C"
"Injury, poisoning and procedural complications",2023-10-29,46,1,0,0,"Group C"
"Injury, poisoning and procedural complications",2023-10-30,53,1,0,0,"Group C"
"Injury, poisoning and procedural complications",2023-10-31,55,1,1,0,"Group C"
"Investigations",2023-11-01,50,1,0,0,"Group C"
"Investigations",2023-11-02,44,1,1,0,"Group C"
"Investigations",2023-11-03,46,1,1,0,"Group C"
"Investigations",2023-11-04,49,1,0,0,"Group C"
"Investigations",2023-11-05,53,1,1,0,"Group C"
"Investigations",2023-11-06,50,1,0,0,"Group C"
"Investigations",2023-11-07,49,1,0,0,"Group C"
"Investigations",2023-11-08,53,1,0,0,"Group C"
"Investigations",2023-11-09,44,1,1,0,"Group C"
"Metabolism and nutrition disorders",2023-11-10,56,1,1,0,"Group C"
"Metabolism and nutrition disorders",2023-11-11,52,1,1,0,"Group C"
"Metabolism and nutrition disorders",2023-11-12,52,1,0,0,"Group C"
"Metabolism and nutrition disorders",2023-11-13,52,1,0,0,"Group C"
"Metabolism and nutrition disorders",2023-11-14,52,1,0,0,"Group C"
"Metabolism and nutrition disorders",2023-11-15,56,1,1,0,"Group C"
"Metabolism and nutrition disorders",2023-11-16,52,1,1,0,"Group C"
"Metabolism and nutrition disorders",2023-11-17,56,1,1,0,"Group C"
"Metabolism and nutrition disorders",2023-11-18,56,1,0,0,"Group C"
"Musculoskeletal and connective tissue disorders",2023-11-19,55,1,0,0,"Group C"
"Musculoskeletal and connective tissue disorders",2023-11-20,54,1,0,0,"Group C"
"Musculoskeletal and connective tissue disorders",2023-11-21,50,1,1,0,"Group C"
"Musculoskeletal and connective tissue disorders",2023-11-22,44,1,0,0,"Group C"
"Musculoskeletal and connective tissue disorders",2023-11-23,46,1,1,0,"Group C"
"Musculoskeletal and connective tissue disorders",2023-11-24,49,1,0,0,"Group C"
"Musculoskeletal and connective tissue disorders",2023-11-25,44,1,1,0,"Group C"
"Musculoskeletal and connective tissue disorders",2023-11-26,54,1,0,0,"Group C"
"Musculoskeletal and connective tissue disorders",2023-11-27,46,1,1,0,"Group C"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2023-11-28,53,1,1,0,"Group C"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2023-11-29,56,1,1,0,"Group C"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2023-11-30,52,1,1,0,"Group C"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2023-12-01,55,1,1,0,"Group C"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2023-12-02,54,1,0,0,"Group C"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2023-12-03,50,1,1,0,"Group C"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2023-12-04,44,1,0,0,"Group C"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2023-12-05,46,1,1,0,"Group C"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2023-12-06,53,1,1,0,"Group C"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2023-12-07,44,1,0,0,"Group C"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2023-12-08,52,1,1,0,"Group C"
"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",2023-12-09,46,1,0,0,"Group C"
"Nervous system disorders",2023-12-10,49,1,1,0,"Group C"
"Nervous system disorders",2023-12-11,53,1,1,0,"Group C"
"Nervous system disorders",2023-12-12,56,1,0,0,"Group C"
"Nervous system disorders",2023-12-13,49,1,0,0,"Group C"
"Nervous system disorders",2023-12-14,56,1,1,0,"Group C"
"Nervous system disorders",2023-12-15,49,1,0,0,"Group C"
"Nervous system disorders",2023-12-16,56,1,1,0,"Group C"
"Pregnancy, puerperium and perinatal conditions",2023-12-17,52,1,1,0,"Group C"
"Pregnancy, puerperium and perinatal conditions",2023-12-18,55,1,0,0,"Group C"
"Pregnancy, puerperium and perinatal conditions",2023-12-19,54,1,0,0,"Group C"
"Pregnancy, puerperium and perinatal conditions",2023-12-20,50,1,0,0,"Group C"
"Pregnancy, puerperium and perinatal conditions",2023-12-21,50,1,0,0,"Group C"
"Pregnancy, puerperium and perinatal conditions",2023-12-22,54,1,0,0,"Group C"
"Pregnancy, puerperium and perinatal conditions",2023-12-23,52,1,1,0,"Group C"
"Pregnancy, puerperium and perinatal conditions",2023-12-24,52,1,0,0,"Group C"
"Psychiatric disorders",2023-12-25,44,1,1,0,"Group C"
"Psychiatric disorders",2023-12-26,46,1,0,0,"Group C"
"Psychiatric disorders",2023-12-27,46,1,0,0,"Group C"
"Psychiatric disorders",2023-12-28,46,1,0,0,"Group C"
"Psychiatric disorders",2023-12-29,44,1,0,0,"Group C"
"Psychiatric disorders",2023-12-30,46,1,1,0,"Group C"
"Psychiatric disorders",2023-12-31,46,1,1,0,"Group C"
"Psychiatric disorders",2024-01-01,44,1,0,0,"Group C"
"Psychiatric disorders",2024-01-02,44,1,1,0,"Group C"
"Psychiatric disorders",2024-01-03,44,1,1,0,"Group C"
"Psychiatric disorders",2024-01-04,44,1,1,0,"Group C"
"Psychiatric disorders",2024-01-05,46,1,0,0,"Group C"
"Reproductive system and breast disorders",2024-01-06,49,1,1,0,"Group C"
"Reproductive system and breast disorders",2024-01-07,53,1,1,0,"Group C"
"Reproductive system and breast disorders",2024-01-08,56,1,0,0,"Group C"
"Reproductive system and breast disorders",2024-01-09,52,1,0,0,"Group C"
"Reproductive system and breast disorders",2024-01-10,53,1,1,0,"Group C"
"Reproductive system and breast disorders",2024-01-11,56,1,0,0,"Group C"
"Reproductive system and breast disorders",2024-01-12,49,1,0,0,"Group C"
"Reproductive system and breast disorders",2024-01-13,52,1,1,0,"Group C"
"Reproductive system and breast disorders",2024-01-14,49,1,0,0,"Group C"
"Respiratory, thoracic and mediastinal disorders",2024-01-15,55,1,1,0,"Group C"
"Respiratory, thoracic and mediastinal disorders",2024-01-16,54,1,0,0,"Group C"
"Respiratory, thoracic and mediastinal disorders",2024-01-17,50,1,1,0,"Group C"
"Respiratory, thoracic and mediastinal disorders",2024-01-18,44,1,0,0,"Group C"
"Respiratory, thoracic and mediastinal disorders",2024-01-19,46,1,1,0,"Group C"
"Respiratory, thoracic and mediastinal disorders",2024-01-20,46,1,1,0,"Group C"
"Respiratory, thoracic and mediastinal disorders",2024-01-21,44,1,1,0,"Group C"
"Respiratory, thoracic and mediastinal disorders",2024-01-22,50,1,0,0,"Group C"
"Respiratory, thoracic and mediastinal disorders",2024-01-23,50,1,0,0,"Group C"
"Respiratory, thoracic and mediastinal disorders",2024-01-24,46,1,0,0,"Group C"
"Respiratory, thoracic and mediastinal disorders",2024-01-25,50,1,0,0,"Group C"
"Respiratory, thoracic and mediastinal disorders",2024-01-26,46,1,0,0,"Group C"
"Skin and subcutaneous tissue disorders",2024-01-27,49,1,1,0,"Group C"
"Skin and subcutaneous tissue disorders",2024-01-28,53,1,1,0,"Group C"
"Skin and subcutaneous tissue disorders",2024-01-29,49,1,1,0,"Group C"
"Social circumstances",2024-01-30,56,1,0,0,"Group C"
"Social circumstances",2024-01-31,52,1,1,0,"Group C"
"Social circumstances",2024-02-01,55,1,1,0,"Group C"
"Social circumstances",2024-02-02,54,1,1,0,"Group C"
"Social circumstances",2024-02-03,50,1,1,0,"Group C"
"Social circumstances",2024-02-04,44,1,1,0,"Group C"
"Surgical and medical procedures",2024-02-05,46,1,0,0,"Group C"
"Surgical and medical procedures",2024-02-06,49,1,0,0,"Group C"
"Surgical and medical procedures",2024-02-07,53,1,1,0,"Group C"
"Surgical and medical procedures",2024-02-08,53,1,1,0,"Group C"
"Surgical and medical procedures",2024-02-09,46,1,1,0,"Group C"
"Surgical and medical procedures",2024-02-10,49,1,0,0,"Group C"
"Surgical and medical procedures",2024-02-11,49,1,1,0,"Group C"
"Vascular disorders",2024-02-12,50,1,0,1,"Group C"
"Vascular disorders",2024-02-13,56,1,0,0,"Group C"
"Vascular disorders",2024-02-14,52,1,0,0,"Group C"
"Vascular disorders",2024-02-15,55,1,1,0,"Group C"
"Vascular disorders",2024-02-16,54,1,1,0,"Group C"
"Vascular disorders",2024-02-17,44,1,1,0,"Group C"
"Vascular disorders",2024-02-18,46,1,1,0,"Group C"
"Vascular disorders",2024-02-19,49,1,1,0,"Group C"
"Vascular disorders",2024-02-20,53,1,0,0,"Group C"
"Vascular disorders",2024-02-21,44,1,1,0,"Group C"
"Vascular disorders",2024-02-22,49,1,1,0,"Group C"
"Vascular disorders",2024-02-23,56,1,1,0,"Group C"
"Vascular disorders",2024-02-24,54,1,0,0,"Group C"
"Vascular disorders",2024-02-25,55,1,0,0,"Group C"
"Vascular disorders",2024-02-26,56,1,1,0,"Group C"
"Vascular disorders",2024-02-27,54,1,1,0,"Group C"
